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Toxicology

Oxidative stress and the guanosine nucleotide triphosphate pool: implications for a
biomarker and mechanism of impaired cell function
Chairperson: Fernando Cardozo-Pelaez, Ph.D.
Oxidation of the guanosine (G) moiety, yielding the oxidized lesion 8-hydroxy-2’deoxyguanosine (oxo82dG), in DNA has become a hallmark biomarker in assessing
cellular outcomes induced by oxidative stress. It is well established that the guanosine
nucleotide triphosphate pool is also susceptible to oxidative stress and suggested to be
more available for oxidation than DNA due to the lack of protective histones and robust
repair mechanisms for reducing the levels of all the products of oxidation. The oxidation
of guanosine in the nucleotide triphosphate pool, resulting in oxidized guanosine 5’triphoshate (oxo8GTP), has been overlooked due to the lack of a reliable method.
Oxo8GTP has been shown to precede oxidation to G incorporated into DNA and
modulate cell processes such as G-protein signaling and RNA synthesis. Evidence is
presented in this study of a reliable method to quantify oxo8GTP, a proposed mechanism
for the oxidative modification of GTP in the presence of copper and L-ascorbic acid, and
evidence of oxo8GTP as an inhibitor of soluble guanylyl cyclase (sGC). A significant
induction of oxo8GTP in cell-free preparations as well as in PC12 and HEK 293T cells
exposed to physiologically relevant oxidative conditions generated with 10 µM copper
sulphate and 1mM L-Ascorbic Acid (Cu/Asc) is also reported. Exposure to oxidative
conditions by Cu/As leads to elevations in oxo8GTP significant enough to result in a
reduction of the sGC product, cyclic guanosine monophosphate (cGMP), by as much as
half in pure sGC and PC12 cells. GTP is protected from oxidation in the presence of
reduced glutathione and this subsequently rescues sGC activity. This suggests that
oxo8GTP is produced by free radicals in vivo and can significantly impact neuronal cell
functions regulated by sGC activity in the central nervous system such as synaptic
plasticity. Alterations in copper homeostasis and oxidative stress have been implicated in
several neurodegenerative disorders including Alzheimer’s and Parkinson’s diseases as
well as Amyotrophic Lateral Sclerosis. Based upon evaluation of the data presented
herein, we hypothesize that neuronal deficiencies in such disorders might be due to
oxidation of the GTP pool and the ensuing effects on neuronal function.
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INTRODUCTION
Maintenance of Cellular Oxidative Status
The careful balance between reductants and oxidants in the cellular pool is
collectively referred to as cellular redox status. The redox status of a cell influences
normal cell functioning processes such as proliferation, differentiation as well as intraand extracellular signaling. It is also thought to play a role in deleterious processes such
as cell death and carcinogenesis. Cellular redox status is a dynamic state dependent on
the levels of free radicals, highly reactive molecular species that contain one or more
unpaired electrons. The most oxidizing free radical found in cells is the hydroxyl radical
(OH) which belongs to a class of oxygen –containing compounds termed reactive
oxygen species (ROS). The superoxide radical ( O2-) and hydrogen peroxide (H2O2) are
also given this designation of abundant cellular ROS. As shown in Table 1 and discussed
in detail below, there are several cellular sources of these ROS as well as complementary
antioxidants and free radical scavengers regulating their relative concentration. The loss
of balance between ROS and antioxidants in the cellular milieu which results in a
deleterious impact on cell function and fate is defined as oxidative stress (Sies 1991).

1

Table 1. Cellular sources and respective antioxidant and free radical scavengers
maintaining the concentration of the most abundant cellular reactive oxygen species.

Adapted from (Halliwell 2007)
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The hydroxyl radical is the ROS with the highest reduction potential (2.31V) and
therefore is the most oxidizing (Buettner 1993). Most of the OH produced in the cell is
a result of the reduction of transition metals such as Fe(II) and Cu(I) in the presence of
H2O2 via the Fenton reaction (Table 1) (Liochev 1999). The initial oxidation of Fe(III)
and Cu(II) to their Fenton-reactive species requires the presence of abundant cellular
reductants such as ascorbate. Superoxide also catalyzes this oxidation of Fe(III) and
Cu(II) thus combining the Fenton reaction with the Haber-Weiss reaction (O2- + H2O2 
O2 + OH + -OH). However, under normal physiological conditions it is thought that
concentrations of O2- are too low to facilitate this reaction (Haber and Weiss 1934;
Halliwell 2007). The cellular concentration of these transition metals in their redoxactive, “free” states is also tightly regulated within physiological limits. This is
accomplished by metal binding proteins such as hemoglobin, myoglobin, and ferritin for
Fe(II) and albumin, cerruloplasmin, and copper chaperones for Cu(II). However, an
increased body burden of both of these Fenton-reactive metals is known to occur with
toxicological insult and disease pathologies which will be discussed later.
Likely due to the extremely short half life of OH which is on the order of
nanoseconds, and its high reactivity in vivo, there are no antioxidant enzymes with the
specific function of removing OH (Pastor, Weinstein et al. 2000). Most scavenging of
this ROS is accomplished by small molecule antioxidants such as α-tocopherol (vitamin
E) and ascorbate (vitamin C) maintained through dietary sources. Oxidative modification
of biomolecules such as proteins, lipids, and DNA is often associated with attack by OH
and the byproducts have been used biomarkers of cellular oxidative stress. These will be
discussed in detail. Recently, it was reported that the major byproduct from the repair of
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oxidatively modified DNA, measured in urine, showed an inverse correlation with blood
plasma levels of vitamins E and C in healthy subjects (Foksinski, Gackowski et al. 2007).
The superoxide radical is far less reactive than OH with a much lower reduction
potential (0.94V) although it has a high rate of physiological production in mitochondria
(Buettner 1993). The mitochondria is the main source of energy production in the form
of ATP synthesis for the cell. This is accomplished by transfer of electrons through the
mitochondrial electron transport chain. Complexes I and III of the electron transport
chain can leak electrons directly to O2 producing O2-. Other sources of O2- are listed in
Table 1 including production by endogenous enzymes, auto-oxidation reactions of
biological molecules such as the neurotransmitters adrenalin and dopamine, and a small
amount of intermediary heme-Fe(III)- O2- formed when O2 binds to iron in hemoglobin
or myoglobin (Yeh and Alayash 2003). There are two main forms of superoxide
dismutase (SOD) responsible for maintaining low intracellular concentrations of O2- :
Copper-zinc SOD (CuZn SOD) located in the cytoplasm, also referred to as SOD1 and
manganese SOD (Mn SOD) located in the mitochondria, also referred to as SOD2. The
function of these enzymes is to catalyze the dismutation of O2- to H2O2 and O2 each
forming an enzyme-metal intermediate with either Cu or Mn (Table 1). The importance
of these antioxidant enzymes has been emphasized in studies of transgenic mice lacking
SOD activity. Deficiency in MnSOD results in perinatal fatality in mice due to severe
central nervous system (CNS) and cardiac degeneration (Lebovitz, Zhang et al. 1996).
Additionally, ablation of the gene for CuZn SOD in mice results in severe damage to the
CNS and vascular dysfunction along with hepatocarcinogenesis and skeletal muscle
atrophy over the life-span of the animals (Reaume, Elliott et al. 1996; Didion, Ryan et al.
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2002; Elchuri, Oberley et al. 2005; Jackson 2006; Muller, Song et al. 2006).
Overexpression of human CuZn SOD has been shown to attenuate age-related increases
in oxidative damage (Cardozo-Pelaez, Song et al. 1998). Conversely, elevated wild-type
CuZn SOD has also been shown to increase oxidative burden in mice potentially due to
the increase in the ROS byproduct of SOD reactions, H2O2 (Peled-Kamar, Lotem et al.
1997).
Hydrogen peroxide is the only ROS discussed that is not, by definition, a free
radical and therefore it is far less reactive than OH or O2- and is a very weak oxidant
with a reduction potential of only 0.32V (Buettner 1993). However, H2O2 is ubiquitous
in physiological tissues and steady-state concentrations have been suggested to be as high
as 10-7M (Halliwell 2007). Due to the ease with which H2O2 crosses cell membranes and
its integral participation in forming the highly damaging OH via the Fenton reaction,
levels are regulated by the presence of specific antioxidant enzymes including catalase
and glutathione peroxidase (GPx) which catalyze the detoxification of H2O2 to H2O and
O2 (Table 1). Deficiencies in catalase in humans, acatalasemia, does not result in overt
pathology although it has been associated with increased risk for the development of
diabetes and vascular disease (Leopold and Loscalzo 2005). Similarly, deletion of the
gene encoding catalase in mice is not fatal although apparently increases susceptibility to
H2O2 generating toxins and cancer development with age (Ho, Xiong et al. 2004). The
lack of overt pathology is likely due to the redundancy in H2O2 scavenging enzymes
within the cell with deficiencies in catalase compensated for by enzymes such as GPx.
Knockout mice lacking GPx show similar susceptibilities to oxidative insults as the
catalase knockout phenotype (Fu, Cheng et al. 1999).
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Another highly active reductant in the cell capable of scavenging free radicals is
the thiol-containing antioxidant reduced glutathione (GSH). GSH, in addition to being a
cofactor for GPx reactions, is also an important small molecule antioxidant independent
of this role. GSH has been shown to interact with OH in vitro, but its primary role in
maintaining redox balance is thought to be by preventing protein thiol groups from
oxidation thus preventing deleterious protein cross-linking. A deficiency in the ratelimiting enzyme for GSH synthesis, γ-glutamylcysteine synthetase, in transgenic mice is
embryonic lethal and a decrease in tissue GSH levels is associated with a range of human
diseases such as Wilson’s disease, Parkinson’s disease, and pulmonary fibrosis (Summer
and Eisenburg 1985; Jenner 1993; Dalton, Dieter et al. 2000; Hudson 2004).
Fluctuations in the redox status of the cell are associated with normal processes of
development and aging as well as the pathogenesis of several diseases and outcomes of
toxicological insult. Levels of ROS are highly influential over this redox status
participating in both beneficial and pathological cellular processes. In order to better
characterize the latter, biomarkers of oxidative stress are often quantified as oxidative
lesions in macromolecules such as DNA. These biomarkers serve a dual role as both
tools with diagnostic potential for diseases and toxicological insults that do not exhibit
signs of obvious pathology and as mechanistic endpoints which could help in the search
for more specific therapeutic interventions.
Oxidative Damage and Repair of Guanine Incorporated into DNA
The oxidative modification of DNA by ROS can generate a number of possible
DNA lesions. Of the two purine DNA bases, guanine and adenine, and the two
pyrimidine DNA bases, cytosine and thymine, guanine has the lowest reduction potential
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and therefore is the most readily oxidized (Devasagayam, Steenken et al. 1991; Steenken
1997; Milligan, Aguilera et al. 2001). Two-electron oxidation of the C8 position of
guanosine, the guanine base with associated ribose sugar, facilitated by OH attack
results in the formation of 8-oxoguanosine (oxo8G) (Table 2). A tautomeric form of this
adduct, 8-hydroxyguanosine (OH8G), is the major oxidation product of guanosine
oxidation at low pH conditions similar to those employed in most analytical detection
methods (Figure 1) (Culp, Cho et al. 1989; Breen and Murphy 1995). However, at
physiological pH = 7.4, oxo8G is the predominant form.
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FIGURE 1

Adapted from (Breen and Murphy 1995; Dizdaroglu, Jaruga et al. 2002)
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Figure 1. Mechanism of two-electron oxidation of guanosine.
Hydroxyl radical attack at the C8 position of guanine causes electron abstraction from the
N7 position forming a C8-OH-adduct reactive intermediate which undergoes oxidation to
form 8-hydroxyguanosine.
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In the 2’-deoxyguanosine (2-dG) form found in DNA, guanine base with
associated deoxyribose sugar, this same mechanism of oxidation by OH results in the
formation of the 8-oxo-2’-deoxyguanosine (oxo82dG) lesion (Kasai and Nishimura
1983). A summary clarifying the nomenclature of these guanine-containing moieties and
their oxidized counterparts is outlined in Table 2.
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Table 2. Nomenclature and description of guanine and oxidized guanine compounds

Adapted from (Halliwell 2007)
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The oxo82dG adduct is one of the most frequently studied of the over twenty oxidized
DNA base products characterized and it attracts considerable interest as a biomarker of
oxidative stress associated with a host of normal and disease-associated physiological
processes including aging, diabetes, and cancer (Dandona, Thusu et al. 1996; Dizdaroglu,
Jaruga et al. 2002; Chiou, Chang et al. 2003). The ultimate consequences of oxo8dG
accumulation are unclear; however, it is known to have deleterious effects in both
proliferating and differentiated cells, leading to the initiation step of carcinogenesis in the
former and apoptosis in the latter. Several reports have shown that oxo8dG can preclude
cellular transformation in proliferating cells, as it has been frequently identified in the
p53 tumor suppressor gene observed in lung and liver cancer (Hollstein, Sidransky et al.
1991). The consequences of oxo8dG accumulation in postmitotic cells such as neurons
appear to be errors in transcription (Chen and Bogenhagen 1993). Oxo8dG accumulation
has been associated with aging and neurodegenerative disease. Basal levels of oxo8dG
have been shown to increase with aging in various rodent tissues, as well as in animal
models of neurological disease (Fraga, Shigenaga et al. 1990; Chen and Bogenhagen
1993; Cardozo-Pelaez, Song et al. 1999; Bogdanov, Andreassen et al. 2001). In agerelated neurodegenerative diseases such as Alzheimer’s (AD) and Parkinson’s Disease
(PD), a significant increase in oxo82dG levels in impacted brain regions and in cerebral
spinal fluid (CSF) as compared to age-matched controls has been demonstrated in postmortem tissue (Table 3).
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Table 3. Percent of oxo82G relative to unmodified 2-dG significantly increased
compared to age-matched controls in Alzheimer’s and Parkinson’s Disease brains.
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Oxidative stress is recognized as an important pathological hallmark of both AD and PD
although the percent of oxo82dG relative to unmodified 2-dG in nuclear DNA from the
brains of patients is as low as 0.005% with an upper limit of only around 1% (Table 3).
The significance of these small percentages of oxo8dG in DNA in disease suggests that
relatively low levels of oxidation may indeed have drastic cellular consequences,
especially in a post-mitotic neuronal cell. Also, given the fact that guanine is more
abundant in other cellular compartments, it raises the possibility that oxidation of guanine
in the genomic DNA pool is not the most robust biomarker of oxidative status. The freeradical theory of aging first introduced in 1956 by Denham Harman suggests that aging
results from the accumulation of oxidative damage to tissue by free radicals. This theory
is supported by the observation that there is an inverse relationship between metabolic
rate and subsequent O2 consumption and lifespan. Measurements of the oxidized guanine
DNA base excision repair product, 8-oxo-7,8-dihydroguanine (oxo8Gua), excreted into
urine verified a positive correlation with metabolic rate and negative correlation with
lifespan which was specific for this lesion as compared to other oxidative DNA repair
products (Foksinski, Rozalski et al. 2004).
There are two mechanisms by which oxo8dG can be incorporated into DNA: (1)
direct modification of DNA by oxyradical attack or (2) by oxidative modification of 2’deoxyguanosine triphosphate (dGTP) substrate used by DNA polymerases during DNA
replication (Figure 2).
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FIGURE 2

Adapted from (Nakabeppu, Tsuchimoto et al. 2007)
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Figure 2. Repair enzymes for oxo8dG lesions in the nucleotide and genomic pool.
Oxo8dG can be incorporated into DNA either by oxidation of dGTP in the nucleotide
pool or direct oxidition to the guanine base in DNA. This can result in G:C to T:A
transversions due to the ability of oxo8dG to pair with adenosine in DNA. MTH1 is the
dGTPase responsible for recognizing and hydrolyzing oxo8dGTP from this nucleotide
pool as a first line of defense against this lesion making its way into DNA. However,
once incorporated into DNA, the Ogg1 glycosylase enzyme recognizes and cleaves this
lesion paired with cytosine and with the help of an apurinic endonuclease (APE), DNA
polymerase (Pol) and DNA ligase (Lig) the DNA is fully repaired. If the oxo8dG lesion
is paired with adenosine after replication, another glycosylase, MutY, will cleave the
adenosine which can then be replaced with cytosine by APE, Pol, and Lig enabling
oxo8dG to be recognized and removed by the activity of Ogg1.
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Oxo8dG is pro-mutagenic due to its tendency to preferentially pair with adenine over
cytosine during DNA replication, leading to G:C to T:A transversions (Hollstein,
Sidransky et al. 1991; Shibutani, Takeshita et al. 1991; Cheng, Cahill et al. 1992). If
antioxidant systems fail to prevent oxidation of G in the dGTP pool or in DNA, cells
have a redundant system of enzymes that catalyze the sanitation of either the oxidized
guanosine nucleotide pool (MTH1), remove oxo8dG from DNA (Ogg1), or after
replication remove the mispaired A to the oxo8dG (MYH).
Oxo8dG is cleaved from DNA by enzymes of the base excision repair (BER)
pathway. BER is initiated by the activity of a bifunctional glycosylase/ AP lyase enzyme.
This enzyme, 8-oxoguanine DNA glycosylase 1 (Ogg1), is able to recognize the oxidized
guanine base (oxo8dG) and cleave it out of the DNA chain (Radicella, Dherin et al.
1997). The human form of Ogg1 (hOgg1) is a bifunctional glycosylase with a
mitochondrial as well as nuclear form which have recently been shown to differentially
regulate cell death under conditions of oxidative stress (Oka, Ohno et al. 2008). The
inactivation of the gene that codes for mouse Ogg1 (mOgg1) has been shown to result in
an accumulation of oxo8dG in mitochondrial and nuclear DNA isolated from liver as well
as decrease the excretion of the Ogg1 cleavage product oxo8Gua (Klungland, Rosewell et
al. 1999; Minowa, Arai et al. 2000; de Souza-Pinto, Eide et al. 2001; Osterod, Hollenbach
et al. 2001; Rozalski, Siomek et al. 2005) (Table 4). Increased susceptibility to
manganese in brain tissue from Ogg1 knock-out mice as compared to wild-type control
has also been demonstrated by a greater loss of dopamine in caudate putamen and a
significantly higher increase in oxo82dG from nuclear DNA isolated from midbrain
(Cardozo-Pelaez et. al. 2005).
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Table 4.

Oxidative modifications in tissue from mice deficient in DNA repair enzymes

18

Additionally, the activity of mOgg1 in specific brain regions appears to be the
determinant of the level of oxo8dG present; conditions that modulate mOgg1 activity in
C57Bl/6J mouse brain and differentiated rat pheochromocytoma (PC12) cells, a cell
culture model of neuronal cells, lead to alterations in oxo8dG levels (Cardozo-Pelaez,
Brooks et al. 2000; Stedeford, Cardozo-Pelaez et al. 2001; Cardozo-Pelaez, Stedeford et
al. 2002). If DNA replication ensues without removal of the oxo8dG from the parent
strand, oxo8dG will preferentially pair with adenosine. Then, the first step in BER will be
initiated by MutY homologue (MYH), an adenine/2-hydroxyadenine glycosylase
mismatch and BER enzyme that will excise adenine and 2-hydroxyadenine paired with
oxo82dG (Figure 2). As with Ogg1, the MYH gene codes for nuclear and mitochondrial
forms (Ohtsubo, Nishioka et al. 2000). Livers isolated from mice deficient in MYH have
been shown to accumulate significantly higher levels of oxo82dG as compared to wildtype, and double knock-out mice lacking Ogg1 and MYH show significant accumulation
of the oxo8dG lesion in liver, small intestine, and lung in adult animals (Table 4) (Russo,
De Luca et al. 2004; Russo, De Luca et al. 2007). The levels of oxo82dG in the brain of
these Ogg1/MYH knock-out animals reveal a trend of increasing oxo82dG accumulation
although not as significant as in organs with proliferating cells.
The oxidized nucleotide triphosphatase, Mut T homolog-1 (MTH1), responsible
for the hydrolysis of 8-oxo-2’deoxyguanosine triphosphate (oxo8dGTP) to its inactive
form, 8-oxo-2’deoxyguanosine monophosphate (oxo8GMP), is the third enzyme that
prevents oxo82dG accumulation in DNA at the level of the nucleotide pool (Mo, Maki et
al. 1992; Sakumi, Furuichi et al. 1993). Mice deficient in MTH1 have been extensively
studied in models of neurotoxicity and demonstrate increased oxo82dG accumulation in
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DNA as well as oxo8G accumulation in RNA in response to oxidative stress from
kainate-induced excitotoxicity or exposure to 1 -methyl-4-phenyl-1,2,3,6tetrahydropyridine (MPTP) (Kajitani, Yamaguchi et al. 2006; Nakabeppu, Tsuchimoto et
al. 2007) (Table 4). In addition to oxo8dGTP and to a much lesser extent 8-oxoguanosine triphosphate (oxo8GTP) , the MTH1 protein is capable of hydrolyzing oxidized
adenine moieties including 2-oxo-deoxyadenosine triphosphate (oxo2dATP), 2-oxo-ATP
(oxo2ATP), 8-oxo-dATP (oxo8dATP), and 8-oxo-ATP (oxo8ATP) (Fujikawa, Kamiya et
al. 1999; Fujikawa, Kamiya et al. 2001).

However, the specific activity of MTH1 for

each of these modified purines is not equal: oxo2dATP > oxo2ATP > oxo8dGTP >
oxo8dATP >> oxo8GTP > oxo8ATP (Fujikawa, Kamiya et al. 2001). In fact, the catalytic
efficiency for oxo8dGTP has been shown to be between forty and fifty times greater than
that for oxo8GTP (Hayakawa, Hofer et al. 1999; Fujikawa, Kamiya et al. 2001). To date,
there are no specific repair mechanisms that compensate for this inefficiency of MTH1 to
remove oxo8GTP from the nucleotide pool. Given the volume of literature that has been
devoted to characterizing the levels and fate of oxo82dG in DNA and the significant
evidence of its association with cancer and neurodegenerative disease, there appears to be
a disproportionate deficit in research attention to the ribonucleotide form of guanosine,
GTP, and the fate of its oxidized counterpart, oxo8GTP. The few studies aimed at
evaluating cellular consequences of increased oxo8GTP in the cell or to test its relative
abundance under conditions of oxidized stress are summarized below.
Cellular Fate of Oxo8GTP
Guanosine 5’-triphosphate (GTP) participates in several critical physiological
functions including but not limited to, RNA synthesis, protein synthesis, cell signaling
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through activation of GTP-binding proteins, and the production of the second messenger
cyclic guanosine monophosphate (cGMP). Oxo8GTP as shown in Figure 3 is the major
product of oxidation to the guanosine moiety of this nucleoside triphosphate.
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FIGURE 3

22

It is assumed that oxidation of guanosine incorporated into GTP is by a similar ROScatalyzed mechanism as shown in Figure 1. Additionally, it has been previously shown
that  OH is produced by electron transfer by Fe(II), Fe(III), and Cu(II) complexed with
nucleotide triphosphates such as GTP in the presence of the abundant cellular reductant
ascorbate (Biaglow, Held et al. 1996). Such Cu complexes are known to affect signal
transduction by acting as second messengers, and depending on their concentration and
the target protein, may be the ultimate factor influencing cell survival or cell death
responses (Filomeni, Rotilio et al. 2005; Filomeni, Cerchiaro et al. 2007). On average,
the concentration of ribonucleotide triphosphate (ATP, GTP, CTP, and UTP) RNA
precursors has been shown to be a hundred times higher than that of deoxyribonucleotide
triphosphate DNA percursors (dATP, dGTP, dCTP, and dTTP). GTP is representative of
this with an average concentration of 468 ± 224 µM reported in mammalian cells
compared to an average concentration for dGTP of 5.2 ± 4.5 µM (Traut 1994). Figure 4
outlines what has been previously determined in research literature regarding the
generation, elimination, and incorporation of oxo8GTP in the cellular milieu.
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FIGURE 4
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Figure 4. Mechanisms of oxo8GTP production, elimination, and utilization.
Oxo8GTP can be formed either by direct modification of the GTP pool, thought to be the
major pathway, or by phosphorylation of oxo8GDP by nucleotide diphosphate kinase.
Ribonucleotide reductase cannot form oxo8dGTP from oxo8GDP. Once in the cellular
pool, oxo8GTP can by hydrolyzed to oxo8GMP by MTH1 although with very low
efficiency. Oxo8GMP is not a viable substrate for guanylate kinase to produce oxo8GDP.
A more efficient hydrolyase specific for oxo8GTP has not been identified to date.
Cellular effects of oxo8GTP reported so far are a decreasae in total mRNA, increase in
mutations in mRNA oxidation and mutations as well as altered G-protein signaling.
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Because guanosine has been well established as a viable substrate for oxidative
modification by ROS in the forms of dGTP, DNA, or RNA, it has been assumed that
oxo8GTP is produced in the cytoplasm by direct oxidation by GTP although the data
presented herein is the first to specifically verify this oxidative modification of GTP by
ROS in a cell culture system (Hayakawa, Taketomi et al. 1995). Oxo8GTP has also been
shown to be a viable substrate for nucleotide diphosphate kinase, and therefore high
levels of oxo8GDP could also promote elevated oxo8GTP (Hayakawa, Hofer et al. 1999).
Early studies confirmed that oxo8GTP is an active substrate for RNA polymerase II and
that it can be misincorporated into RNA opposite adenine instead of cytosine, inducing
translational errors in the resulting protein (Taddei, Hayakawa et al. 1997).

Recently,

studies have confirmed these errors in transcription induced by oxidative modification of
RNA precursors. It was demonstrated that the addition of oxo8GTP to in vitro
transcription reactions reduces the total amount of mRNA synthesized as well as
increases the number of mutations in the mRNA (Kamiya, Suzuki et al. 2007). These
findings have substantial implications for post-mitotic cells such as neurons that depend
on RNA fidelity for the maintenance of cellular protein expression and function. It has
been suggested that expression of transcription elongation factor S-II confers resistance
to transcriptional errors induced with oxidative stress by cleaving out misincorporated
bases (Koyama, Ito et al. 2003). However, there has not been a specific RNA repair
mechanism identified for recognizing and excising oxidized bases and as stated above,
the activity of MTH1 is not sufficient to prevent the formation of substantial amounts of
oxidized RNA precursors such as oxo8GTP. The deleterious implication of this is
emphasized by evidence of increased levels of oxidized RNA adducts in the brains of
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idiopathic neurodegenerative disease patients including Alzheimer’s disease, Parkinson’s
disease, and Lewy body disease (Nunomura, Perry et al. 1999; Zhang, Perry et al. 1999;
Nunomura, Chiba et al. 2002; Shan, Tashiro et al. 2003; Shan and Lin 2006). Oxo8GTP
can also affect G-protein signaling although currently there is only one study that has
investigated this. Yoon et. al. demonstrated that incubating purified, recombinant Ras or
cell lysates from human embryonic kidney (HEK 293T) cells with oxo8GTP resulted in
an increased Ras activity by as much as two times the level induced by the unmodified
GTP substrate (Yoon, Hyun et al. 2005). Given that oxo8GTP is more potent than the
native substrate of Ras, the authors suggest that oxo8GTP is not simply a by-product
formed with oxidative stress but a physiologically-active molecule that participates in
cell signaling. Interestingly, the effects of oxo8GTP were not consistent amongst the
other GTP-binding proteins analyzed. When oxo8GTP was incubated with purified Rac1,
purified Cdc 42, or cell lysates from HEK 293T cells there was no detectable activity
(Yoon, Hyun et al. 2005). Therefore, it appears that oxo8GTP does interact with GTPbinding proteins although the effects are not uniform and this poses the question of
whether GTP might be a target for oxidative modification as a mediator of the cellular
response.
Roles of GTP with a Focus on the Nervous System
Cellular consequences of oxo8GTP in post-mitotic neurons are completely
unknown. A cellular target of GTP important for neurotransmission as well as
physiological processes such as vasodilation and platelet aggregation is soluble guanylyl
cyclase (sGC) [E.C. 4.6.1.2.] (Moncada, Palmer et al. 1991). To stay within the scope of
this introduction, the discussion of sGC will focus on implications for the central
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nervous system. sGC is a heterodimer consisting of an α and β subunit and is activated
by the co-factor nitric oxide (NO) binding to a heme prosthetic group on the β subunit
which then facilitates the conversion of the substrate GTP to the product cyclic guanosine
5’-monophosphate (cGMP) (Craven and DeRubertis 1978; Gerzer, Bohme et al. 1981).
sGC is located in the cytoplasm and is distinct from the particulate or membrane-bound
guanylyl cyclase which is differentially regulated and insensitive to NO (Waldman and
Murad 1987). Figure 5 depicts the regulation of sGC as well as the targets of cGMP, the
intracellular messenger product of sGC activation. The ultimate fate of generated cGMP
from sGC activation is stimulation of cGMP-dependent kinases, cGMP-regulated ion
channels, and cGMP-regulated phosphodiesterases (Francis, Blount et al. 2005) (Figure
5).
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FIGURE 5

Adapted from (Friebe and Koesling 2003)
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Figure 5. Regulation and cellular fate of soluble guanylyl cyclase activity.
Nitric oxide (NO) synthase is the endogenous enzyme that catalyzes the production of
NO from L-arginine for use by soluble guanylyl cyclase (sGC). Synthetic NO donors
including DEA/NO are often used in experimental settings to activate sGC. Inhibitors of
NO synthase and therefore sGC activity include LY83583 and methylene blue. NO is a
necessary co-factor for the conversion of GTP to cGMP by sGC. Specific inhibitors that
interfere with NO binding to a heme-binding domain of sGC include ODQ and NS 2028.
The product of cGMP activation acts on several downstream targets including cGMPdependent kinases, cGMP-regulated phosphodiesterases, and cGMP-regulated ion
channels.
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Several synthetic stimulators and inhibitors of sGC have been used for experimental and
therapeutic investigations (Gruetter, Kadowitz et al. 1981; Garthwaite, Southam et al.
1995; Schrammel, Behrends et al. 1996; Olesen, Drejer et al. 1998; Hobbs 2002). Table
5 lists the two synthetic inhibitors of sGC, ODQ and NS2028, that have shown specificity
for the enzyme as opposed to interference with available NO.
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Table 5. Kinetic properties of synthetic sGC inhibitors.
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Methylene blue and 6-anilino-5,8-quinolinedione (LY83583) have also been employed in
investigations ablating the NO/sGC/cGMP pathway however, they are known to inhibit
neuronal nitric oxide synthase (NOS), the endogenous enzyme responsible for converting
L-arginine to NO in neurons, as opposed to direct interaction with the sGC protein (Luo,
Das et al. 1995) (Figure 5). Table 6 lists the effects of pharmacological inhibition of sGC
on endpoints of neurotoxicity that have been evaluated.
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Table 6. The effects of pharmacological inhibition of sGC on endpoints of neurotoxicity.
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Modification of the NO/sGC/cGMP pathway has been shown to elicit deleterious
consequences in the central nervous system (CNS) including reduced neuronal activation,
impairment of long term potentiation (LTP), inhibition of long-term depression (LTD),
and the disruption of neurodevelopmental processes (Table 6) (Zhuo, Hu et al. 1994;
Arancio, Kandel et al. 1995; Boulton, Southam et al. 1995; Tanaka, Markerink-van
Ittersum et al. 1997; Bidmon, Starbatty et al. 2004; Boess, Hendrix et al. 2004; Monfort,
Munoz et al. 2004; Yamazaki, Chiba et al. 2006). A lot of emphasis has been placed on
the NO/sGC/cGMP pathway as an essential mechanism for observed increases in longlasting synaptic plasticity defined as long-term potentiation (LTP), the physiological
correlate of learning (Bliss and Collingridge 1993). There are several biochemical
processes that take place during synaptic strengthening as a conequence of LTP but they
all appear to converge with respect to signaling by NO that leads to the eventual increase
in expression of proteins necessary for the strengthening of the synaptic connectivity.
This is exemplified by the fact that animals deficient in neuronal NOS show reduced LTP
and demonstrate significant cognitive impairment in learning and memory tasks as
compared to wild-type controls (Son, Hawkins et al. 1996; Kirchner, Weitzdoerfer et al.
2004). As a neuronal target of NO, sGC plays an important role amongst these processes.
It has been shown that pharmacological inhibition of sGC prevents LTP in the
hippocampus of rats and guinea pigs, a region of the brain highly associated with learning
and memory processes (Table 6) (Zhuo, Hu et al. 1994; Arancio, Kandel et al. 1995;
Boulton, Southam et al. 1995; Son, Lu et al. 1998; Monfort, Munoz et al. 2002). Similar
LTP impairment has been shown to occur in primary hippocampal neurons isolated from
rat brain (Table 6). It is hypothesized that sGC activation leads to an increase in
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available cGMP required to activate cGMP-dependent kinases that go on to
phosphorylate transcription factors such as cAMP responsive element (CRE)-binding
protein (CREB) which in turn promotes an increase in RNA synthesis necessary to
increase proteins required for synaptic strengthening (Lu, Kandel et al. 1999). Colocalization of NOS and sGC on pre and post-synaptic densities in hippocampal neurons
strengthens the conclusions of the integral role that sGC plays in the cellular mechanisms
that lead to LTP (Burette, Zabel et al. 2002). Modulations in NO-responsive sGC
expression and activity have also been associated with a variety of disorders including
cardiovascular disease and neurological diseases such as Alzheimer’s Disease (AD),
Creutzfeldt-Jakob disease, and multiple sclerosis, all of which include a component of
oxidative stress in their pathologies (Bonkale, Winblad et al. 1995; Baltrons, Pifarre et al.
2004; Puzzo, Vitolo et al. 2005; Moncada and Higgs 2006). This oxidative stress is
hypothesized to be mediated, in part, by an aberrant increase in Fenton-reactive metals
such as copper in AD brains (Lovell, Robertson et al. 1998; Huang, Atwood et al. 1999;
Maynard, Cappai et al. 2002; Bush 2003; Rossi, Arciello et al. 2006). However, the
oxidative stress hypothesis associated with increases in transition metal-induced increases
in ROS has not been evaluated in terms of the sGC/cGMP pathway.
Copper, ROS, and Alzheimer’s Disease
All of the main neurodegenerative diseases that manifest in cognitive deficiencies include
a component of aberrant protein folding and aggregation in their pathology. In the brain
of Alzheimer’s disease (AD) patients, the misfolded proteins collect into amyloid beta
(Aβ) plaques. Protein plaques also denote the hallmark feature of prion disease (PrPD)
and in Parkinson’s disease (PD) intracellular aggregates are identified as Lewy bodies
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(Taylor, Hardy et al. 2002). Additionally, in familial amyotrophic lateral sclerosis (ALS),
the presence of Bunina bodies verify disease state (Taylor, Hardy et al. 2002). Another
unifying feature of these diseases, facilitated by the collection of these proteins, is altered
homeostasis of one or more metal ions, namely Zn (II), Cu(II), and Fe(III) (Bush 2003).
However, analysis of postmortem brain tissue from patients with some of these
neurodegenerative diseases is either unavailable or misleading due to the lack of a
reliable methodology (i.e. without acid sample preparation required for inductivelycoupled plasma mass spectrometry (ICP-MS) to measure these metal ions complexed to
proteins in tissue (Corrigan, Reynolds et al. 1993; Wong, Chen et al. 2001). However,
AD tissue has been analyzed using micro-PIXE analysis in stained tissue which
overcomes this methodology obstacle. Lovell et. al. reported a 30% increase in copper
in senile plaques of AD brain as compared to plaque-free regions as well as a 400%
increase in copper in neutropils of AD as compared to age-matched, healthy controls
(Lovell, Robertson et al. 1998). The interactions of the Aβ peptide, both insoluble Aβ142

and soluble Aβ1-40, with copper has been described (Atwood, Scarpa et al. 2000). There

are two basic hypothesis about the reactions of metal-protein complexes in these diseases:
(1) the presence of metal ions facilitates the aggregation of misfolded proteins or (2)
metal ions catalyze reactions producing ROS that cause cellular damage via oxidative
stress (Gaggelli, Kozlowski et al. 2006). These hypotheses are not mutually exclusive
however and it is suggested that oxidative processes lead to protein damage that further
exacerbates the progression of the disease causing an auto-destructive process (Bayer,
Schafer et al. 2006). There is a massive amount of information available in the research
literature regarding these hypothesis as they relate to several neurodegenerative diseases
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and metals ions, including the ones listed above (Molina-Holgado, Hider et al. 2007).
However, to stay within the scope of this study, focus will be placed on the production of
ROS by Cu(II) specifically in relation to the pathology of AD.
Sources of ROS in AD brain tissue include Aβ-catalyzed H2O2 generation through
the reduction of Cu2+ using O2 and biological reducing agents such as ascorbic acid as
substrates (Huang, Atwood et al. 1999). Reduced copper ions (Cu+) can then participate
in the Fenton reaction with H2O2 to produce the highly reactive OH. radical. In fact, it
has been shown that the Aβ peptide does not produce toxic amounts of H2O2 in the
absence of Cu(II) (Opazo, Huang et al. 2002). However, it has been suggested that Aβ
might be part of a normal metal clearance mechanism which becomes unregulated when
there is excessive metal concentration that overwhelms this clearance system, causing
aggregation and pro-oxidant behavior (Bush 2003). This could help explain evidence of
Aβ plaques in normal, non-demented elderly brains (Katzman, Terry et al. 1988;
Arriagada, Marzloff et al. 1992; Giannakopoulos, Hof et al. 1995; Davis, Schmitt et al.
1999). Additionally, the Tg2576 transgenic mouse models of AD that express the
Swedish mutation of human amyloid precursor protein (APP) and collect significant
levels of Aβ plaque by 12 months of age fail to present consistent behavioral measures of
age-dependent cognitive decline or gross neuronal death (Irizarry, McNamara et al. 1997;
Chen, Chen et al. 2000; Westerman, Cooper-Blacketer et al. 2002; Lesne, Kotilinek et al.
2008). Support for the role of copper in conferring toxicity of the Aβ peptide also comes
from successful investigations of copper chelation. The copper chelator
iodochlorhydroxyquin (clioquinol) has been investigated in human AD patients in clinical
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trials as well as mouse models of AD and shown to have potential therapeutic benefit
(Cherny, Atwood et al. 2001; Ritchie, Bush et al. 2003).
As suggested earlier, there is a careful balance between Aβ, copper, and ROS that
exists in normal aging brain physiology that appears to be severely disrupted in AD. An
increasing amount of evidence has been presented proposing that the onset of AD is
preceded by an interim phase of dementia pathology termed Mild Cognitive Impairment
(MCI) (Petersen and Negash 2008). Analysis of CSF, urine, and blood of MCI patients
reveals an increase in lipid peroxidation compared to age-matched controls (Pratico,
Clark et al. 2002; Wang, Markesbery et al. 2006). Evidence of early oxidative events in
AD has also been supported by analysis of urine, plasma, and brain tissue of Tg2576
mice that show an elevation in lipid peroxidation, a biomarker of oxidative stress also
found in AD patients (Pratico, Clark et al. 2000). This lipid peroxidation precedes the
formation of amyloid plaques and exhibits an age-dependent increase that parallels
amyloid pathology in this model (Pratico, Uryu et al. 2001). Unfortunately, analysis of
copper content in the brains of these mice have excluded protein-bound levels of Cu(II)
and prevent correlation with early oxidative events (Maynard, Cappai et al. 2002).
Identifying the triggers and endpoints of this unbalanced copper homeostasis can aid in
AD research in two important avenues: (1) identification of biomarkers of sporadic AD
that lead to earlier diagnosis and (2) development of therapeutic intervention strategies
that inhibit these initial events in AD that precede gross neuronal loss. Anaylsis of GTP,
dGTP and their oxidized counterparts oxo8GTP and oxo8dGTP could generate a
substantial amount of information to forward research in these avenues.
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The hypothesis that is presented and tested herein is that oxo8GTP is produced
under physiological conditions and it is increased during oxidative stress induced by
toxicological insult or neurodegenerative disease. A consequence of elevated oxo8GTP
levels is a reduction in available cyclic guanosine monophosphate (cGMP) due to its
activity as a pathological inhibitor of soluble guanylyl cyclase (sGC). This hypothesis
will be tested with the following specific aims:
Specific Aim 1. Determine the levels of oxo8GTP produced in cell-free GTP
preparations and cytosolic extracts from cells in culture under conditions of oxidative
stress induced by ascorbate and copper using a novel HPLC-EC methodology.
Specific Aim 2. Determine the specific mechanism of oxidation to GTP induced by
ascorbate and copper using EPR.
Specific Aim 3. Evaluate the consequences of increased levels of oxo8GTP on sGC
activity.
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CHAPTER ONE
Assessing biomarkers of oxidative stress: Analysis of guanosine and oxidized
guanosine nucleotide triphosphates by high performance liquid chromatography
with electrochemical detection
Abstract
Oxidation of the guanosine moiety in DNA has become a hallmark biomarker in
assessing oxidative stress. The oxidation of guanosine in the nucleotide triphosphate pool
has been overlooked due to the lack of a reliable methodology. This method describes a
sample processing and high performance liquid chromatography with electrochemical
detection protocol for the analysis of the cellular pool of guanosine triphosphates and
oxidized guanosine triphosphates. Validation of this method is demonstrated along with
evaluation of these analytes in control and oxidizing conditions in vitro and in HEK 293T
cells. Oxidation of this triphosphate pool occurred independently of oxidation to DNA.
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Introduction
Oxidative stress is defined as the deleterious impact in cell function as a
consequence of the loss in homeostatic balance between reactive oxygen species (ROS)
and antioxidants in the cellular milieu (Sies 1991). ROS are formed continuously as a
result of normal cellular respiration, enzymatic metabolism, and exogenous insults
(Halliwell and Gutteridge 1986). Oxidative stress has been implicated in the onset and
development of several pathological processes including cancer and age-related
neurodegenerative diseases such as Parkinson’s Disease (PD) (Hollstein, Sidransky et al.
1991; Sanchez-Ramos 1994; Alam, Jenner et al. 1997; Beal 2003). The interaction of
ROS with DNA has the potential to generate a number of possible DNA lesions. Among
the four DNA bases, guanine has the lowest reduction potential and it is the most readily
oxidized (Devasagayam, Steenken et al. 1991; Steenken 1997; Milligan, Aguilera et al.
2001). Two-electron oxidation of guanine results in the formation of 8-oxo-2’deoxyguanosine (oxo8dG), which is the major oxidation product of guanine. This species
is one of the most frequently studied oxidized DNA base products, and it has attracted
considerable interest as a biomarker of oxidative stress associated with diseases ranging
from cancer to neurological deficits (Dizdaroglu, Jaruga et al. 2002; Proteggente,
England et al. 2002; Chiou, Chang et al. 2003; Wang, Xiong et al. 2005). It has been
shown that oxo8dG is produced by hydroxyl radical (OH.) attack, the most oxidizing ROS
to arise in biological systems, on the C8 position of 2’-deoxyguanosine (2-dG) in DNA
(Kasai and Nishimura 1983; Buettner 1993). Oxo8dG is promutagenic due to its
tendency to preferentially pair with adenosine over cytosine during DNA replication,
leading to G:C → T:A transversions (Cheng, Cahill et al. 1992). Increases in oxo8dG
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levels in DNA can also occur after OH. radical attack to the cellular 2’-deoxyguanosine
5’-triphosphate (dGTP) pool producing oxidized 2-dG 5’-triphosphate (oxo8dGTP)
(Hayakawa, Taketomi et al. 1995). Oxo8dGTP can then be incorporated into DNA
during cellular replication or during DNA repair. The dGTP nucleotide pool is mainly
located in the cytoplasm; therefore, it is more available for attack by ROS as compared to
DNA, which is protected by histones and tightly packaged in the nucleus.
Guanosine 5’-triphosphate (GTP), required for RNA synthesis and several normal
cellular functions, can also be modified by ROS. GTP concentrations in the cytoplasm
are hundreds of times larger than dGTP (Kornberg 1992). This suggests that under
conditions of high ROS levels, significantly more oxidized GTP (oxo8GTP) than
oxo8dGTP could be produced in the cell. However, due to the lack of a reliable way to
quantify these oxidation products, little is know of the degree of oxidation to dGTP or
GTP pools after ROS attack and the possible impact of these oxidation products to
cellular physiology. Recently it has been shown that the dGTP pool endures greater
levels of oxidation after irradiation as compared to DNA (Haghdoost, Czene et al. 2005).
Levels of oxo8dG in cells, tissue, and whole animal have been reported as an important
biomarker for oxidative stress when evaluating disease pathologies ranging from cancer
to diabetes (Hollstein, Sidransky et al. 1991; Dandona, Thusu et al. 1996). However,
most of this evidence has been accrued by assessment of oxo8dG via antibody
technology. It is necessary to investigate the relative contributions of oxidized dGTP and
GTP to this biomarker assessment as well as the particular susceptibility of these cellular
pools to oxidative stress as compared to DNA.
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The following study describes a sample processing and HPLC-EC methodology
for the simultaneous determination of dGTP, GTP, oxo8dGTP, and oxo8GTP in cells.
Optimization of retention times was achieved by dephosphorylating the compounds to
their respective guanosine nucleoside forms 2-deoxyguanosine (2dG), guanosine (G), and
their corresponding oxidized forms oxo8dG and oxo8G, and detection selectivity was
gained by detection at specific voltages by the coularray detector. Although hydrolysis of
guanosine nucleotide triphosphates to their respective guanosine nucleosides by alkaline
phosphatase (EC 3.1.3.1) has been reported as a preparative step for HPLC with UV
detection, validation of this technique as a reliable assessment of dGTP and GTP
concentrations in the cells concomitantly with assessment of their oxidized forms,
oxo8dGTP and oxo8GTP, has not been established until now (Cohen, Maybaum et al.
1981). The method described here was used to quantify the basal levels of dGTP and
GTP in human embryonic kidney (HEK 293T) and to assess the susceptibility of theses
pools to ROS attack. Oxo8dG was quantified in nuclear DNA extracts of the HEK393T
cells under oxidizing conditions that impacted the GTP pool, and shown to be equal to
that of controls. Thus, these results suggest a novel way of assessing the oxidation of
cellular guanosine triphosphates as a biomarker of oxidative stress that occurs
independently from oxidation to DNA. The sample processing and chromatographic
analysis presented permit us to demonstrate that under conditions in which ROS are
produced, the GTP pool can be impacted without noticeable changes to the dGTP pool or
the guanine base in DNA.
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Materials and Methods
Chemicals and Reagents
All reagents were purchased from Sigma-Aldrich (St. Louis, MO), unless otherwise
indicated. 8-oxoguanosine-5’-triphosphate (oxo8GTP) and 8-oxo-2’-deoxyguanosine-5’triphosphate (oxo8dGTP) were purchased from TriLink Biotechnologies (San Diego,
CA). 8-oxoguanosine (oxo8G) was obtained from Cayman Chemical (Ann Arbor, MI).
Ultrapure water was obtained from a Milli-Q UF-Plus apparatus (Millipore).
Cell culture
HEK 293T cells purchased from American Type Culture Collection (Menasses,
VA) were grown in T75 cell culture flasks (Costar, Corning Inc., Corning, NY) at 37° C,
5% CO2. Cells were maintained in 1X Dulbecco’s Modification of Eagle’s Medium with
4.5 g/L glucose and L-glutamine, 10% fetal bovine serum, 1 mM sodium pyruvate, 1X
non-essential amino acids, 1000 international units (IU) penicillin – 1 mg/mL
streptomycin, and 50 µg/mL gentamicin sulfate. All media reagents were purchased
from CellGro® technologies (Mediatec Inc., Herndon, VA, USA). All in vitro
experiments were conducted with harvested cells that had reached confluency,
approximately 3 x 107 cells per flask. Mycophenolic Acid (MPA) was solubilized in
ethanol and diluted in cell culture media for MPA experiments. A final concentration of
2 µM MPA was added in a subset of cell colonies and incubated for one hour at 37oC, a
dose previously shown not to affect cell viability (Gu, Gathy et al. 2003). For oxidation
experiments, control cell populations were incubated in 1mM L-ascorbic acid and
oxidation colonies contained 1mM L-ascorbic acid and 10 µM cupric sulfate. All
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reagents were prepared in media before addition to flasks and incubation at 37oC for four
hours.
dGTP, GTP, oxo8dGTP, and oxo8GTP extraction
All the extraction steps were performed on ice. Immediately prior to processing,
confluent flasks of HEK 293T cells were assessed for viability using the tryphan blue
exclusion method and counted. After washing three times with ice-cold phosphatebuffered saline (PBS), cells were harvested with the addition of 3 mL of 1X trypsinEDTA and pelleted by centrifugation at 2,000 x g, 4oC. Cell pellets were pooled from
two flasks per sample in 6mL of PBS. Following centrifugation, protein was precipitated
using 1.5mL of 6% Trichloroacetic Acid (TCA), vortex-mixed for 20s, ice-bathed for 10
minutes, and vortex-mixed again for 20s. Cell extracts were then centrifuged at 13,000
rpm for 10 minutes at 4oC. The resulting supernatant was neutralized to pH 6 with a
solution containing 3M KOH and 3M KHCO3. Samples were stored at -80oC until
undergoing the dephosphorylation process.
dGTP, GTP, oxo8dGTP, and oxo8GTP dephosphorylation
Neutralized cell extracts, standards, and in vitro reactions were treated similarly
for dephosphorylation. On ice, 25 Units of alkaline phosphatase (dissolved in Tris-HCl
pH 8.0), 1.8 mM sodium acetate, and 100mM Tris-HCl, were added to 10µL of sample in
total volume of 20 µL. After incubation at 37oC for 1 hour, the dephosphorylation
reaction was stopped by placing on ice. This was followed by filtering through UltrafreeMC (30-kD) tubes (Millipore Corp., Bedford, MA). Quantification of the generated
nucleosides (2-dG, G, oxo8dG and oxo8G) was carried out by injecting 10µL of the
filtrate into the HPLC-EC for in vitro reactions and 20µL of filtrate for cell extracts.
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Instrument and Chromatographic Conditions
Guanosine nucleotide triphosphates, guanosine nucleosides, and oxidized
derivatives were resolved by HPLC with a reverse phase YMC basic column (4.6 x 150
mm; particle size 3-micron) (YMC Inc., Wilmington, NC) and quantified using a
CoulArray electrochemical detection system (ESA, Inc., Chelmsford, MA). An isocratic
mobile phase consisting of 100 mM sodium acetate, pH 5.2, 4% Methanol (HPLC Grade)
diluted in water polished with C18 Sep-Pak cartridges (Waters Corp., Milford, MA) was
utilized to elute the guanosine nucleotide triphosphates and guanosine nucleosides from
the column. The mobile phase was filtered using 0.2 µm nylon filters and degassed by
sonication before use with the HPLC. Potentials of the twelve coulometric analytical cells
of the CoulArray system, placed in series, were as follows: 50, 125, 175, 200, 250, 380,
500, 700, 785, 850, 890, 900 mV. Data were recorded, analyzed, and stored using
CoulArray for Windows data analysis software (ESA Inc., Chelmsford, MA).
Calibration standards
Stock solutions of each analyte were prepared by individually dissolving
commercially available, pure guanosine and oxidized guanosine nucleosides as well as
guanosine nucleotide triphosphates in mobile phase. For the nucleosides 2-dG and G,
the addition of 5 µL of 10M NaOH to 1mL of stock solution was required to achieve
adequate solubility. Calibration curves were generated from standards of dGTP, GTP, 2dG, and G ranging from 5 pmoles to 4 nmoles. Elution of the guanosine-containing
analytes was monitored in the 700, 785, and 850 mV channels and their injected amounts
were graphed relative to the sum of peak areas. Oxo8dGTP, oxo8GTP, oxo8dG, and
oxo8G calibration curves were created from concentrations ranging from 5 to 50 pmoles.
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These oxidized guanosine analytes were monitored in the 250 mV channel and their
injected amounts were graphed relative to peak area of the corresponding peak.
Dephosphorylated calibration standards were treated similarly with the addition of the
dephosphorylation steps outlined in 2.4.
Oxidation of GTP in vitro
All reagents for in vitro oxidations were reconstituted in PBS, pH = 7.4, and kept
on ice. Control reactions included 1 mM GTP and 1 mM L-ascorbic acid and oxidation
reactions contained 1 mM GTP, 1 mM L-ascorbic acid, and 10 µM cupric sulfate in a
final volume of 100 µL. All samples were incubated for 4 hours at 37oC.
DNA isolation
DNA was extracted from confluent flasks of HEK 293T cells, with minor
modifications, according to a method previously described (Bolin, Stedeford et al. 2004).
Briefly, confluent flasks of control populations were treated with unmodified cell culture
media described above (see 2.5). Oxidized populations were exposed to a final
concentration of 10 µM cupric sulfate and 1 mM L-ascorbic acid prepared in cell culture
media and incubated for 4 hours at 37oC. After washing three times with ice-cold
phosphate-buffered saline (PBS), cells were harvested with the addition of 3 mL of 1X
trypsin-EDTA and pelleted by centrifugation at 2,000 x g, 4oC. Pellets were resuspended
in 1 mL of DNA extraction buffer containing 0.1 M Trizma-base, 0.1 M NaCl, and 20
mM EDTA, and lysed by sonication using a Vir Sonic Ultrasonic Cell Disruptor 100
(Virtis Company, Gardiner, NY). Following sonication, 300 µL of DNA extraction
buffer containing 33 U of DNase free RNase T1 (EC 3.1.27.3) and 200 µg of RNase A
(EC 3.1.27.5) and incubated at 37oC for 1 hour. After mixing and brief centrifugation at
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1,500 x g for 5 minutes, 300 µL of DNA extraction buffer containing 300 µg of
Proteinase K (EC 3.4.21.64) and 1% SDS was added to each sample. Following
incubation at 37 oC for 1 hour, the protein fraction was separated from the DNA by three
consecutive organic extractions as follows: 700 µL of phenol (stored at –20 oC saturated
in buffer) was added to the mixture and after homogenization and centrifugation the
aqueous phase was transferred to 1.5 mL microcentrifuge tubes containing Light Phase
Lock Gel (Brinkmann Instruments, Inc., Westbury, NY). The samples were then
extracted with phenol:chloroform:isoamyl alcohol (25:24:1), and chloroform:isoamyl
alcohol (24:1). The DNA was precipitated from the aqueous phase with two volumes of
ice-cold ethanol (with respect to aqueous volume) and stored overnight at -20 oC.
Extracted DNA was prepared for the HPLC analysis by resolving it into
deoxynucleoside components. The DNA was denatured by digestion at 90 oC for 2
minutes in 100 µL of 20 mM sodium acetate (pH 5.0) then incubating at 37 oC for 1 hr
with 10 U of nuclease P1 (EC 3.1.30.1) (dissolved in 20 mM sodium acetate). Each
sample was then treated with 10 U of alkaline phosphatase (dissolved in Tris-HCl pH
8.0) and incubated at 37 oC for 1 hour. The reaction was stopped by addition of 20 µL of
3 M sodium acetate (pH 5.0), then filtered using Ultrafree-MC (30-kD) tubes and
lyophilized. Samples were stored at -80oC and reconstituted in 50 µL of mobile phase
before HPLC-EC analysis. Injection volumes for HPLC-EC analysis contained 10 µL of
sample.
Statistical Analysis
All data were analyzed using Prism GraphPad 4.0 software (Graph pad Software
Inc., San Diego, CA). Calibration curve parameters for each of the analytes were
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obtained by linear regression analysis. An unpaired t-test was performed on data from
MPA and oxidation experiments; values denoted with an asterisk are significantly
different from their corresponding controls (P < 0.05).
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Results
Detection of guanosine and oxidized guanosine moieties
Our chromatographic conditions allowed for the separation of guanosine (dGTP,
GTP, 2-dG, and G) and oxidized guanosine moieties (oxo8dGTP, oxo8dG, oxo8GTP, and
oxo8G) of interest. Figure 6A and 6B were obtained by injection of a single standard
containing the six guanosine compounds shown (GTP, dGTP, G, 2-dG, Oxo8G, Oxo8dG).
Figure 6C was obtained by injection of standards containing known quantities of
oxo8dGTP and oxo8GTP. Although the retention times for oxo8dGTP and oxo8GTP
overlap with those of dGTP and GTP, selectivity for their analysis is gained by detection
at different oxidation potentials. Both compounds, especially oxo8dGTP, do not seem to
coelute with any other. Elution of the guanosine triphosphates is monitored in the 700,
785, and 850 mV channels (Figure 6A), while elution of the oxidized forms is monitored
in the 250 mV channel where the maximum aplitude signal is observed (Figure 6C).
However, when using extracts from biological samples for HPLC-EC analysis, the
difference in chemical composition between the mobile phase and biological milieu
generates a broad solvent front in the first four minutes of the analysis. This solvent
front peak overlaps the elution of peaks generated from the guanosine triphosphates and
makes their analysis impossible. Given the good resolution for the analysis of 2-dG and
G (Figure 6A) and for oxo8dG and oxo8G (Figure 6B) combined with their low levels in
biological systems, we opted to analyze the triphosphates after an additional sample
preparation step to dephosphorylate these analytes before injecting them into the HPLCEC.

59

FIGURE 6
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Figure 6. Chromatographic profiles for GTP, dGTP, G, and 2-dG
Chromatographic profiles for a standard containing GTP, dGTP, G, and 2-dG (A)
detected in channels set at 700, 785, and 850 mV, a standard containing oxo8G and
oxo8dG detected with a channel set at 250 mV (B), and standards of oxo8GTP and
oxo8dGTP detected at 250 mV (C).
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Validation of preparative sample dephosphorylation
To test whether the dephosphorylation step would interfere with the electrochemical
analysis of the analytes, we constructed calibration curves for each of the triphosphate
moieties after dephosphorylation and compared their response to injections of equivalent
amounts of standards of their respective guanosine nucleosides (Figure 7). Figure 7A
compares the response of 2-dG generated from dephosphorylation of dGTP to the
response of a prepared 2-dG standard. Figures 7B, 7C, and 7D were constructed similarly
to allow for the same comparison for G, oxo8dG, and oxo8G respectively. The calibration
curves for the dephosphorylated oxidized guanosine triphosphates and oxidized
guanosine nucleosides were built based on a picomolar scale and those for the
unmodified guanosine compounds were built based on a nanomolar scale. This is due to
the observation that the concentration of oxidized guanosine nucleotide triphosphates
(oxo8GTP and oxo8dGTP) and oxidized guanosine nucleosides (oxo8G and oxo8dG)
might be several orders of magnitude smaller than their corresponding unmodified
guanosine compounds (dGTP, GTP, G, 2-dG) in biologically relevant systems.
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FIGURE 7
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Figure 7. Calibration curves for 2-dG, G, oxo8dG, and oxo8G
Solid lines are calibration curves built with known amounts of 2-dG(A), G (B), oxo8dG
(C), and oxo8G (D). Dashed lines are calibration curves built with equivalent amounts of
standards containing dGTP (A), GTP (B), oxo8dGTP (C), and oxo8GTP (D) after alkaline
phosphatase treatment. (n = 2).

64

Table 7 outlines the specific calibration components of each of the dephosphorylated
guanosine triphosphates as well as the guanosine nucleoside standards. Each of the
calibration curves yielded a coefficient of determination (r2) greater than 0.9 and an
average percent recovery of 95% or greater. The values for the slope and intercept for
the dephosphorylated guanosine nucleotide triphosphates as compared to their
corresponding standard guanosine nucleoside were not significantly different.
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Table 7. Comparison of calibration curve components of guanosine nucleosides and
deposhorylated guanosine nucleotides
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It can be therefore concluded that the dephosphorylation of guanosine and oxidized
guanosine triphosphates is complete under these reaction conditions, and that the levels
of the resulting nucleoside are equivalent to the levels of the parent nucleotide
triphosphate. The limit of detection (LOD) for each nucleoside was determined as the
amount giving a signal-to-noise (S/N) ratio of 3:1. The LOD for each compound were
126.83 (G), 167.91 (dG), 40.24 (oxo8G), and 47.11 (oxo8dG) fmole, respectively. The
limit of quantification (LOQ) for each nucleoside was determined as the amount giving a
S/N ratio of 10:1. The LOQ for each compound were 422.80 (G), 559.70 (dG), 134.10
(oxo8G), and 157.0 (oxo8dG) fmole, respectively. These detection limits are one to two
orders of magnitude lower than the levels of G, dG, oxo8G, and oxo8dG measured in
biological samples using this methodology (see Sections 3.3 and 3.4).
Detection of guanosine and oxidized guanosine moieties in HEK 293T cells
To test whether the same dephosphorylation process could be applied to the analysis
of nucleotide triphosphates in biological samples, we used HEK 293T cells with and
without the addition of mycophenolic acid (MPA). MPA is a non-nucleoside,
noncompetitive, reversible inhibitor of inosine monophosphate dehydrogenase (IMPDH)
(EC 1.1.1.205) (Allison and Eugui 2000). IMPDH is responsible for catalyzing the ratelimiting step in the de novo biosynthesis of guanosine monophosphate (GMP) which is
further converted into guanosine diphosphate (GDP) and GTP. Previous studies have
shown that concentrations of MPA ranging from 0.2 to 2 µM reduce the levels of GTP in
vitro as much as eighty percent without affecting cell viability (Daxecker, Raab et al.
2001; Gu, Gathy et al. 2003). Figure 8A and 8B are representative chromatograms of
dephosphorylated cytosolic extracts from control and MPA-treated HEK 293T cells.
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Addition of 2 µM MPA for one hour significantly reduced GTP levels by 70% (Fig. 8A
and 8C) without affecting the concentration of dGTP (Fig. 8D) or cell viability.
Interestingly, oxo8GTP was also significantly reduced by 70% in these same MPAexposed colonies (Fig. 8E). Oxo8dGTP was undetectable in control and MPA-exposed
samples.
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FIGURE 8
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Figure 8. Chromatographic profiles of GTP in HEK 293T cell extracts
Typical chromatograhic profiles of cytosolic cellular extracts, after treatment with
alkaline phosphatase, obtained from HEK 293T cells in control or MPA-exposed
populations (2 µM, 1 hour). Typical retention times for G and 2-dG generated are
presented in 3A, and that for oxo8G in 3B (chromatograms reflect a 3D shift for display
purposes). Although channels 700, 785, and 850 mV were used for quantitation of GTP
and dGTP, only dominant channel 785 mV is shown in this figure for clarity. Bar graphs
show cellular levels of GTP (C), dGTP (D), and oxo8GTP (E) in control (black bar) and
MPA treated (white bar) cells. Values expressed as nanomoles (dGTP and GTP) or
picomoles (oxo8GTP) per 106 cells. Data expressed as the mean ± SEM (n =3-4, * p <
0.05).
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Basal levels of 2-dG, G, oxo8dG, and oxo8G were undetectable in control cell populations
that did not undergo the preparative dephosphorylation step (data not shown). Therefore,
endogenous concentrations of these free guanosine (2-dG and G) and oxidized guanosine
nucleosides (oxo8dG and oxo8G) in the cellular pool do not confound direct detection and
analysis of the dephosphorylated guanosine triphosphate. The concentrations of GTP,
dGTP, and oxo8GTP based on an average cell volume of 820 µm3 was calculated at 2.58
mM, 0.139mM, and 0.762 nM, respectively (Tsao, Condon et al., 2000). Thus, we
conclude that determination of these nucleosides is a valid approach to determine levels
of the original nucleotide triphosphate.
Oxidation of guanosine triphosphates in vitro and in HEK 293T cells
To assess the impact of oxidative damage in the guanosine triphosphates cellular
pools, initially we exposed GTP to a known ROS producing system (1 mM L-ascorbic
acid and 10 µM cupric sulfate). Figure 9A and 9B are representative chromatograms of
the analysis of GTP, after alkaline phosphatase treatment, under control and oxidizing
conditions.
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FIGURE 9
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Figure 9. Chromatographic profiles of GTP exposed to oxidizing conditions
Chromatograhic profiles of dephosphorylated GTP (A) and oxo8GTP (B) after GTP
exposure to control (1 mM L-ascorbic acid) or oxidizing conditions (1 mM L-ascorbic
acid and 10 µM cupric sulfate). Bar graph shows nanomoles of GTP (C) and picomoles
oxo8GTP (D) in GTP samples exposed to control (black bar) or oxidizing conditions
(white bar). Data expressed as the mean ± SEM (n =6-9, * p < 0.05).
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Production of OH. in mixtures of Cu2+ and ascorbate has been previously demonstrated,
and therefore OH. is likely the ROS responsible for producing oxo8GTP via the same
attack mechanism that produces oxo8dG in DNA (Biaglow, Held et al. 1996). The
average percent recovery of GTP incubated in PBS for 4 hours was 101% using this
sample processing and HPLC-EC method which shows that no GTP is lost due to
decomposition or due to the reaction conditions. Under oxidizing conditions,
approximately four times more oxo8GTP was formed as compared to control reactions
that were incubated with L-ascorbic acid alone (Fig. 9D). Pre-treatment of reagents with
the Chelex 100 resin (sodium form) to remove any trace metals did not affect oxo8GTP
levels under control conditions. Oxo8GTP was undetectable in untreated GTP reactions
(data not shown). GTP also showed a small, although significant decrease in
concentration after incubation under oxidizing conditions due to its direct oxidation (Fig.
9C).
To determine if the same oxidation conditions can induce oxo8GTP in a cell culture
system, we exposed HEK 293T cells to similar conditions as the ones described above (1
mM L-ascorbic acid, 10 µM cupric sulfate). Figure 10A and 10B are representative
chromatograms of alkaline treated cytosolic extracts from HEK 293T cells under control
and oxidizing conditions.
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FIGURE 10
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Figure 10. Chromatographic profiles of GTP in oxidized HEK 293T cells
Chromatographic profiles of alkaline phosphatase treated cytosolic cellular extracts
obtained from HEK 293T cells in control (1 mM L-ascorbic acid) or oxidizing (1 mM Lascorbic acid, 10 µM cupric sulfate) conditions. Typical elution profiles for the generated
G and 2-dG (A) and typical elution profile for the oxo8G generated (B). Bar graphs
represent cellular levels of GTP (C), dGTP (D), and oxo8GTP (E) in control (black bar
and treated cell populations (white bar). Data expressed as levels per 106 cells. Data
expressed as the mean ± SEM (n =3, * p < 0.05).
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Oxo8GTP extracted from HEK 293T cells exposed to L-ascorbic acid and cupric sulfate
were six times higher than control populations exposed to L-ascorbic acid alone (Fig.
10E). Exposure to L-ascorbic acid alone (control) decreased oxo8GTP levels as
compared to untreated cells (data not shown). GTP concentrations in oxidized
populations were apparently decreased from controls although the difference was not
significant (Fig. 10C). This is likely due to the normal increase in the variability of data
obtained from cell cultures as compared to purified reagents. dGTP levels were
unaffected in all groups (Fig. 10D) and oxo8dGTP was undetectable in all groups.
Oxidation to guanosine moiety in nuclear DNA of HEK 293T cells
To test whether similar free radical conditions had an effect in the levels of oxidized
guanosine in DNA, we measured oxo8dG level in DNA from HEK 293T cells that were
exposed to L-ascorbic acid and cupric sulfate. Figure 11 demonstrates that nuclear DNA
extracted from HEK 293T cells treated under the same oxidation conditions did not show
an increase in oxidation to the guanosine moiety. This suggests the nucleotide pool,
specifically GTP, is the primary target for oxidation after exposure to mild oxidizing
conditions.
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FIGURE 11
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Figure 11. Levels of oxo8dG in DNA isolated from oxidized HEK 293T Cells
Levels of oxo8dG, as compared to the levels of 2-dG, in DNA isolated from HEK 293T
cells exposed to 1 mM L-ascorbic acid (control, black bar) or 1 mM L-ascorbic acid, 10
µM cupric sulfate (oxidizing conditions, white bar). Data expressed femtomoles of
oxo8dG per nanomoles of 2-dG in DNA. Bars represent mean ± SEM (n =4).
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Discussion
The GTP pool has not been adequately investigated as a target of oxidation and
therefore as a biomarker of oxidative stress. Until now, this paucity of information is in
part due to the lack of a reliable method to assess oxidized guanosine moieties in the
nucleotide pool. The present method for simultaneous detection of dGTP, GTP,
oxo8dGTP, and oxo8GTP is the first report of a sensitive, reliable method for the direct
determination of these guanosine triphosphates in cells. In addition, this method allows
for the detection of the impact of ROS to cellular guanosine under conditions that do not
evidence oxidation to DNA. Reports of oxidative damage to DNA in disease and after
toxicological challenge have relied on assessments using antibodies against oxo8dG
(Degan, Shigenaga et al. 1991; Yin, Whyatt et al. 1995; Toyokuni, Tanaka et al. 1997;
Kikuchi, Takeda et al. 2002). However, these antibodies are notorious for showing crossreactivity with oxo8G, G, and 2-dG (Degan, Shigenaga et al. 1991; Yin, Whyatt et al.
1995). Immunohistochemical studies using antibodies for oxo8dG have also displayed
high background reactivity in both the nucleus and cytosol in various cell types. This
demonstrates unreliable discrimination between oxidized moieties in DNA and in the free
guanosine nucleoside or guanosine nucleotide triphosphate forms (Toyokuni, Tanaka et
al. 1997; Kikuchi, Furuta et al. 2002).
Determination of nucleotide concentrations has been investigated by several
methods including gas chromatography (GC), bioluminescence, nuclear magnetic
resonance spectroscopy (NMR), and high-performance liquid chromatography (HPLC)
(Werner 1993). It has been generally established that the quantification of nucleoside and
deoxynucleoside triphosphates is most reliably assessed via ion-pair HPLC with UV
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detection (Huang, Zhang et al. 2003). However, HPLC with electrochemical detection
(EC) is the most sensitive and reliable way of quantifying oxo8dG (Bolin, Stedeford et al.
2004). The chemical properties of guanosine and oxidized guanosine in their
triphosphate forms make reverse-phase HPLC-EC incapable of accurately detecting these
analytes from biological samples. Incorporation of a preparative dephosphorylation step
to overcome difficulties in detecting analytes eluting in the solvent front of the
chromatogram ensured the ability to measure dGTP, GTP, oxo8dGTP, and oxo8GTP in
cell extracts in a single run. Although basal oxo8dGTP concentrations in biological
samples were below the detection limit, sensitivity to this analyte was shown in Figure
6C. Free 2-dG, G, oxo8dG, or oxo8G were not detected in cell extracts that did not
undergo the preparative dephosphorylation step, thus they do not interfere with
measurements of their triphosphate forms via alkaline phosphatase dephosphorylation.
Alkaline phosphatase cleaves the 5’ phosphates in ribo and deoxyribonucleotide
triphosphates with no activity on nucleotide diphosphates and little activity on nucleotide
monophosphates (Humphreys, Kaysen et al. 1980). Given the substrate specificity of
alkaline phosphatase for nucleotide triphophates and the inability of HPLC methods with
similar extraction techniques to detect GDP or GMP, inflation of G levels using the
presented method by interference of GDP or GMP is unlikely (Metz, Rabaglia et al.
1992). The reduction of GTP and oxo8GTP by MPA, a specific inhibitor of de novo GTP
synthesis in vivo, provided further validation of the sample preparation and HPLC-EC
conditions presented.
The concentration of GTP in HEK 293T cells was found to be approximately tenfold higher than the concentration of dGTP which corroborates earlier studies in various
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normal and tumor cell lines (Huang, Zhang et al., 2003; Traut, 1994) (see Fig.8). The
GTP pool also proved to exhibit higher basal levels of oxidation as compared to the
dGTP pool which was undetectable under normal growth media conditions (see Fig. 8).
The higher basal levels of oxo8GTP, as compared to oxo8dGTP, can be explained by the
presence of a specific cellular repair mechanism for the removal of oxo8dGTP from the
deoxynucleotide pool. The MTH1 (EC 3.1.6.) protein is responsible for hydrolyzing
oxo8dGTP to oxo8dGMP and thus preventing its incorporation into DNA (Mo, Maki et al.
1992). Although MTH1 also acts on oxo8GTP, it has been shown that the rate of
cleavage of oxo8GTP by MTH1 is 50 times lower than that of oxo8dGTP (Hayakawa,
Hofer et al. 1999). No specific repair or removal mechanism for oxo8GTP has been
identified to compensate for this inefficiency of MTH1. This fact also can help explain
why the levels of oxo8GTP in HEK 293T cells exposed to oxidizing conditions
represented an approximately 6-fold increase from control with no observable increase in
oxo8dGTP (see Fig. 10) . Interestingly, this increase in oxo8GTP levels is approximately
twice the magnitude of increase seen in oxo8GTP from direct oxidation of GTP (see Fig.
9). Previous studies investigating 1mM ascorbate as a free radical scavenger in solutions
of purified 2-dG and calf thymus DNA exposed to radiation have also demonstrated
discrepancies in the degree of oxidation to the guanosine moiety (Svoboda and HarmsRingdahl 1999). Although these particular experiments suggested free 2-dG was more
susceptible to oxidation as compared to 2-dG incorporated into DNA, they support the
fact that oxidation of the guanine base is highly dependent on the moiety it is contained
within the cell (free nucleoside, DNA, nucleotide triphosphate, etc.).
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Oxidation of the guanosine moiety in DNA is one of the most widely reported
biomarkers of oxidative stress due to its implications in mutagenesis as well as ease and
reliability of assessment methods. However, the percent of oxidized guanosine relative to
unmodified guanosine in DNA in tissues from pathologies such as Alzheimer’s Disease
and Parkinson’s Disease ranges between 0.002 and 1%. The percent of oxo8GTP relative
to GTP in HEK 293T cells exposed to mild oxidizing conditions used in this study was
0.15%. This is at the upper end of this range for oxo8dG/ 2-dG seen in neurodegenerative
diseases and an order of magnitude higher than the average percent of oxo8dG relative to
2-dG found in the DNA isolated from the blood of patients with diabetes mellitus
(Dandona, Thusu et al. 1996). Oxo8dG measured in naked DNA under similar copper
and ascorbate oxidation conditions, 500 µM and 50 µM respectively, reflects only a 0.1%
oxidation of the total 2-dG (Spear and Aust 1995). Our in vitro oxidations of GTP
demonstrated that 6.6% of the guanosine moiety in its nucleotide triphosphate form was
oxidized to oxo8GTP. This is over 60 times more oxidation to the GTP pool as compared
to DNA treated under more severe oxidative conditions (Spear and Aust 1995). The
magnitude of oxidation we observe both in vitro and in cell culture in the GTP pool
under mild oxidative conditions that do not produce any measurable increase in oxidation
to guanosine in DNA evidences the importance of evaluating this guanosine pool as an
previously overlooked, important marker of oxidative stress.
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Conclusions
In conclusion, dephosphorylation of dGTP and GTP and their oxidized
counterparts via alkaline phosphatase coupled to HPLC-EC analysis has proven to be a
valid method for the detection and analysis of oxidative modification to the guanosine
triphosphate pool. This method can be extended to studies evaluating biomarkers of
oxidative stress and their pathophysiological role in cancer, neurological disease, and
toxicological insult.
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CHAPTER TWO
A mechanism for the production of oxidized guanosine 5’-triphosphate (oxo8GTP):
hydroxyl radical production by a GTP-Cu(II) complex in the presence of L-ascorbic
acid
Abstract
Levels of oxidized guanosine (G) base in DNA have become a hallmark
biomarker in assessing oxidative stress implicated in a variety of disease and toxininduced states. However, there is evidence that the G in the nucleotide triphosphate pool
(GTP) is more susceptible to oxidation than Gs incorporated into nucleic acids and this
causes a substantial amounts of the oxidized product, 8-oxoguanosine 5’-triphosphate
(oxo8GTP), to accumulate in cell-free and in cell culture preparations. Electron
paramagnetic resonance (EPR) spectroscopy and direct EPR analysis of free radical
production by copper sulfate and L-ascorbic acid demonstrates that the hydroxyl radical
( OH) is produced via oxidation of Cu+ to Cu2+ while in a complex with GTP. This


OH production is dependent on the availability of oxygen and the presence of GTP in

the reaction milieu. Verification of free radical-mediated production of oxo8GTP is
presented using HPLC with electrochemical (EC) detection and matrix-assisted laser
desorption/ionization linear time-of-flight mass spectrometry (MALDI-LTOF-MS). The
sum of these results is presented in a novel mechanism of GTP oxidation by Cu2+ and Lascorbic acid. A better understanding of the chemistry involved in this oxidative
modification of GTP facilitates a more comprehensive understanding of its potential
physiological consequences.
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Introduction
Oxidative stress is defined as the deleterious impact on cell function or viability
as a consequence of the loss in balance between reactive oxygen species (ROS) and
antioxidants in the cellular milieu (Sies 1991). ROS are formed continuously as a result
of normal cellular respiration, enzymatic metabolism, and exogenous insults (Halliwell
and Gutteridge 1986). An excess of ROS is known to induce damage to DNA and the
cellular nucleotide pool, yielding DNA strand breaks as well as specific oxidized bases in
DNA. 8-oxo-7,8-dihydro-2`-deoxyguanosine (oxo8dG) is the most prevalent form of
oxidative base modifications produced by the reaction of a hydroxyl radical ( OH) at the
C8 position of 2`-deoxyguanosine (dG) incorporated into DNA or in the guanine
incorporated in the cytosolic nucleotide triphosphates form (dGTP and GTP) (Hayakawa,
Taketomi et al. 1995; Einolf, Schnetz-Boutaud et al. 1998; Russo, Blasi et al. 2004). The
nucleotide pool has been recently been investigated as a significant target for oxidative
stress given that GTP is more accessible for OH -mediated oxidative modification than
the deoxynucleoside form, dG, incorporated into DNA (Svoboda and Harms-Ringdahl
1999; Haghdoost, Sjolander et al. 2006; Bolin and Cardozo-Pelaez 2007). Substantial
evidence has been presented that much of the biologically relevant oxidation occurs in
the cytosol at the nucleotide pool level (Haghdoost, Sjolander et al. 2006).
GTP comprises nearly 25% of the intracellular nucleotide triphosphate pool, it
acts as a versatile nucleotide participating in many critical physiological functions
including RNA synthesis, cell signaling through activation of GTP-binding proteins, as
well as the production of the second messenger cyclic guanosine monophosphate (cGMP)
(Strader, Fong et al. 1994). It has been previously shown that  OH is produced by
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electron transfer by Fe(II), Fe(III), and Cu(II) complexed with nucleotide triphosphates
such as GTP in the presence of the abundant cellular reductant ascorbate (Biaglow, Held
et al. 1996). Additionally, such Cu complexes are known to affect signal transduction by
interfering with second messenger systems, and depending on their concentration and the
target, these Cu complexes may be a major factor influencing cell survival or cell death
responses (Filomeni, Rotilio et al. 2005; Filomeni, Cerchiaro et al. 2007). Oxidation to
the GTP pool produces the oxidized adduct 8-oxoguanosine 5’-triphosphate (oxo8GTP)
(Figure 3). It is unknown how the increase in  OH by Cu complexes such as Cu(II)-GTP
in the presence of reductants might effect the various cellular targets of GTP either
directly or indirectly due to the oxidation of GTP itself. Despite the high cellular
abundance of GTP and the availability of Cu, the specific mechanism of  OH production
by GTP in the presence of Cu(II) and ascorbate has not been investigated.
Copper is contained within all respiring tissues as an essential trace element, a
micronutrient essential for cell survival, as well as a cofactor for several metalloenzymes
(e.g. Cu,Zn-SOD, cytochrome c oxidase) (Kaim and Rall 1996; Solomon, Sundaram et al.
1996). However, in some pathological conditions, copper homeostasis is lost and the
toxicological consequences have been ascribed to its potential to act as a catalyst for
oxidative damage by redox cycling between univalent (Cu(I)) and divalent (Cu(II))
oxidation states (Klomp, Lin et al. 1997; Rossi, Lombardo et al. 2004; Rossi, Arciello et
al. 2006). In particular, redox cycling in the presence of partially reduced oxygen species
such as hydrogen peroxide (H202) and superoxide anion (O2 -) is believed to result in the
generation of the highly reactive and damaging  OH via the Haber-Weiss cycle (eq. 1-3)
[15]. Hence, the copper ion has been highly implicated in ROS-mediated damage in the
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high concentrations that occur in diseases such as Alzheimer’s Disease, familial
amyotrophic lateral sclerosis, and Creutzfeldt-Jacob Disease (Rossi, Arciello et al. 2006).
Cu2+ + H2O2 → Cu+ + O2 -

(1)

2 O2 - + 2H+ → H2O2 + O2

(2)

Cu+ + H2O2 →

(3)

Cu2+ +



OH + -OH

The goal of this study is to identify the free radical chemistry of  OH production
by Cu(II) complexed with GTP in the presence of ascorbate. In order to assess the
mechanism by which copper ions catalyze the oxidation of GTP in the presence of Lascorbic acid, we detected the generation of ROS by EPR spin trapping. We also
evaluated the influence of pH, copper and GTP concentration, and oxygen consumption
on the production of  OH and oxo8GTP along with verification of the Cu(II)-GTP
complex formed during the oxidation process. Our results are compiled to propose a
mechanism for this reaction.
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Materials and Methods
Materials
All reagents were purchased from Sigma-Aldrich (St. Louis, MO), Merck & Co. Inc.
(Whitehouse Station, NJ) or Fisher Scientific (Pittsburgh, PA) and were analytical grade
or better. 8-oxoguanosine-5’-triphosphate (oxo8GTP) was purchased from TriLink
Biotechnologies (San Diego, CA). 8-oxoguanosine (oxo8G) was obtained from Cayman
Chemical (Ann Arbor, MI). Cu(II) isatin-diimine complex [Cu(Imine)] used in the
control reaction was synthesized by condensation reaction of the amine ligand 2aminoethyl pyridine with isatin, followed by metallation with Cu(II) ions added as
perchlorate salt, according to the procedures in the literature (Cerchiaro, Aquilano et al.
2005). All buffers were pre-treated with Chelex-100 to remove metal ion contamination.
All solutions were prepared with distilled water purified in Milli-Q UF-Plus apparatus
(Millipore Corp., Bedford, MA).
EPR Spin-Trapping Instrument Conditions
Electronic spectra were recorded on a Shimadzu 1500 spectrophotometer with
temperature regulated cell compartment. EPR spectra were recorded in a Bruker EMX
Plus Electron-Spin Resonance Spectrometer System instrument, operating at X-band
frequency. We utilized standard Wilmad quartz tubes maintained at 77 K for frozen
solutions or a flat 200 µL quartz cell for spin trapping experiments at room temperature.
DPPH (α,α´-diphenyl-β-picrylhydrazyl) was used as frequency calibrant (g = 2.0036)
with samples in frozen water solution at 77 K. Typical conditions used in these
measurements were 2.00 x 104 gain, and 10 G modulation amplitude.
Reaction Conditions for EPR Analysis
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To examine the production of radicals during the incubations of copper, GTP and
ascorbic acid, EPR spin trapping experiments were performed utilizing 5,5dimethylpyrroline N-oxide (DMPO) as a spin trap. A typical incubation mixture
contained 10 µM copper sulfate (CuSO4.5H2O), 1 mM GTP, and 1 mM L-ascorbic acid
maintained in phosphate buffered acid solution (pH 4). Reactions were diluted in 10mM
phosphate buffered saline (PBS) with the addition of 80 mM DMPO, pH 7.4. The
reaction mixtures were monitored over several time points between one and 30 minutes.
The spectra were recorded at room temperature (22 ± 1 °C) on a Bruker EMX Plus
Electron-Spin Resonance Spectrometer System instrument at X-Band equipped with a
high sensitivity cavity (4119HS). The magnetic field and the quantification of radical
production were measured with a standard aqueous solution of 4-hydroxy-2,2,6,6tetrametyl-1-piperidiniloxy (TEMPOL, g = 2.0056). All EPR spin trapping experiments
were conducted in replicates of three.
Oxymetry Conditions
Oxygen measurements were carried out in a GILSON oxygraph apparatus (Medical
Electronics Inc. USA). A Clark platinum electrode was used as an O2 probe with an
internal reference probe containing a Ag/AgCl solution and a YSI membrane (Yellow
Spring Instruments, Yellow Sprins, OH). A saturated KCl solution was maintained
between the electrode and the membrane. A 1.5 mL volume standard cell was utilized in
these experiments enclosed with a capillary cap, ensuring no oxygen was exchanged with
the atmosphere, and incubated in a water bath maintained at 22.0 ± 0.2 °C with constant
stirring. Sodium dithionite was used to calibrate the oxygraph. Oxymetry experiments
were conducted in replicates of three.
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Quantification of Oxo8GTP by HPLC-EC
Oxo8GTP was quantified using HPLC-EC with preparative dephosphorylation as
described previously (Bolin and Cardozo-Pelaez 2007). A typical reaction contained 10
µM Cu(II) sulfate, 1mM GTP, and 1 mM L-Ascorbic Acid diluted in PBS, pH 7.4 exactly
as described above. Incubations were maintained at 37oC for four hours. Oxo8GTP was
then dephosphorylated to it’s nucleoside form, 8-oxoguanosine (oxo8G), for detection via
HPLC-EC. On ice, 25 Units of alkaline phosphatase (dissolved in Tris-HCl pH 8.0), 1.8
mM sodium acetate, and 100 mM Tris-HCl, were added to 10 µL of sample in total
volume of 10 µL. After incubation at 37oC for 1 hour, the dephosphorylation reaction
was stopped by placing on ice. This was followed by filtering through Ultrafree-MC (30kD) tubes (Millipore Corp., Bedford, MA). Detection of the generated nucleoside oxo8G
was carried out by injecting 10 µL of the filtrate into the HPLC. Oxo8G was resolved by
HPLC with a reverse phase YMC basic column (4.6 x 150 mm; particle size 3-micron)
(YMC Inc., Wilmington, NC) and quantified using a CoulArray electrochemical
detection (EC) system (ESA, Inc., Chelmsford, MA). An isocratic mobile phase
consisting of 100 mM sodium acetate, pH 5.2, 4% Methanol (HPLC Grade) diluted in
water polished with C18 Sep-Pak cartridges (Waters Corp., Milford, MA) was utilized to
elute oxo8G from the column. The mobile phase was filtered using 0.2 µm nylon filters
and degassed by sonication before use with the HPLC. Potentials of the twelve
coulometric analytical cells of the CoulArray system, placed in series, were as follows:
50, 125, 175, 200, 250, 380, 500, 700, 785, 850, 890, 900 mV. Data were recorded,
analyzed, and stored using CoulArray for Windows data analysis software (ESA Inc.,
Chelmsford, MA). Oxo8G was monitored in the 250 mV channel and injected amounts
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were graphed relative to peak area. A calibration curve for oxo8G was generated from
known quantities ranging from 10.0 picomoles to 500 picomoles. Oxo8G quantified in
reactions were reported as oxo8GTP.
Verification of Oxo8GTP formation by MALDI-LTOF
GTP reactions and standards were analyzed using negative-mode, matrix-assisted laser
desorption/ionization linear time-of-flight mass spectrometry (MALDI-LTOF-MS) as
previously described with minor modifications (Edwards and Kennedy 2005). Standards
and reaction mixtures diluted in methanol were mixed in a 1:1 ratio with 9 mg/mL of 9aminoacridine (9-AA) matrix in acetone for deposition. An aliquot of 1 µL of these
mixtures were deposited onto a single spot on a 96-well, stainless steel (SS), MALDI
sample plate and allowed to dry at room temperature (Applied Biosystems, Foster City,
CA). Analysis was performed using a Voyager-DE Pro MALDI-TOF mass spectrometer
using the negative linear mode of operation (Applied Biosystem, Foster City, CA). The
following settings were used for each analysis: accelerating voltage of 20,000V,
acquisition mass range between 60 and 600 Dalton, laser intesity of 2000, and laser
repetition rate of 20.0Hz. Data was acquired with 50 laser shots/spectrum. Spectra were
analyzed using Data Exploreer Version 4.0.0.0 (Aplied Applied Biosystem, Foster City,
CA). The oxo8GTP analyte was confirmed by comparing spectra to standard
preparations of purified oxo8GTP and GTP.
Statistical Analysis
All data were analyzed using GraphPad 4.0 software (GraphPad Software Inc., San
Diego, CA). A one-way ANOVA with a Newman–Keuls multiple comparison test post-
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hoc analysis was performed on the oxo8GTP data presented; values denoted with an
asterisk are significantly different from their corresponding control (p < 0.05).
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Results
Production of  OH by Cu(II)-GTP
Figure 12 shows representative EPR spectra from reactions of GTP and copper
sulfate diluted in PBS at pH 7.4 in the presence of equimolar L-ascorbic acid. A
constant ascorbyl radical background signal was detected in control experiments
containing only L-ascorbic acid and DMPO (Figure 12, spectra A-B).
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FIGURE 12
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Figure 12. EPR spectra of GTP, L-ascorbic acid, and Cu(II)
A) and B) EPR spectra of control experiments in PBS, pH =7.4, 1 mM L-ascorbic acid,
and 80mM DMPO incubated for 2 min (A) and 30 min (B). C) to H) EPR spectra of
reactions of 1 mM GTP, 1 mM L-ascorbic acid, 10 µM Cu(II) sulfate, and 80mM DMPO
in air-saturated PBS, pH 7.4 solution. C’) to H’) EPR spectra of reactions exactly as in C
to H, with the exception that the PBS pH 7.4 solution is devoid of oxygen by saturation
with argon for 30 minutes. All spectra were collected at room temperature (22 °C) and
plotted on the same scale (magnetic field and intensity of EPR) for comparison. EPR
conditions: receiver gain 5.02 x 104, modulation amplitude 1 G, time constant 163.84 ms,
frequency 9.687 GHz, power 20 mW and 1024 points resolution.
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Interestingly, in our reactions under experimental conditions (copper/GTP/L-ascorbic
acid) the signal from the ascorbyl radical increased in the first 2-5 minutes and then
decreased over the course of 30 minute incubation (Figure 12, spectra C to H). We also
confirmed the initial formation of DMPO/•OH adduct, characterized by aN = aH EPR
hyperfine parameters of 14.9 G (Figure 12, spectra C). After 10 minutes, this signal is no
longer detected (Figure 12, spectrum E). The relatively small signal from DMPO/•OH is
due to the low concentration of GTP and Cu(II) ion. We also performed experiments
under low oxygen conditions by bubbling Argon into the solution during the 30 minute
incubation as well into all stock solutions included in the reactions (Figure 12, spectra C’
to H’). This resulted in a lower concentration of DMPO/•OH adduct at the early time
points of incubation, and greater ascorbyl radical detection at later time points as
compared to PBS and stock solutions saturated in atmospheric oxygen (Figure 12,
spectrum C’ to H’). This finding indicates that oxygen participates directly in the
reaction mechanism. Low oxygen concentration resulted in a slower extinction of the
ascorbyl radical and a decrease in •OH production as compared to reactions saturated in
higher, atmospheric oxygen. Hydroxyl radicals react with dimethyl sulfoxide (DMSO) at
a high velocity with second order rate constant of about 109 M-1 s-1, generating a methyl
radical trapped by DMPO (DMPO/•CH3) (Figure 13) (Zhang, Joseph et al. 2000).
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FIGURE 13
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Figure 13. EPR spectra of GTP, L-ascorbic acid, and Cu(II) with DMSO
Experiment conducted in PBS, pH =7.4, 1mM L-ascorbic acid, and 80 mM DMPO
incubated for 1 min (A) or 3 min (B). EPR conditions: receiver gain 5.02 x 104,
modulation amplitude 1 G, time constant 163.84 ms, frequency 9.687 GHz, power 20
mW and 1024 points resolution.
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To confirm the formation of •OH, DMSO was added into the incubations mixtures and
the DMPO/•CH3 adduct (aN = 16.4 G and aH = 23.4 G) was detected while the ascorbyl
radical signal remained unchanged (Figure 13).
To compare the differences in the radical generation during GTP oxidation,
between Cu(II) ion free in solution and Cu complexed with GTP, an organic Cu(II)
complex [Cu(Imine)] was used as model of a stable Cu(II) complex in the reaction. In
these experiments, the Cu(II) sulfate solution was substituted with Cu(Imine) which
contains an imine ligand derivate from the oxindole isatin (Cerchiaro, Aquilano et al.
2005; Filomeni, Cerchiaro et al. 2007). The resulting EPR spectra from spin trapping
experiments were very similar to those using Cu(II) sulfate as a catalyst. This suggests
that the Cu(II) ion in this reaction is complexed and the electron recycling between Cu(II)
and Cu(I) is facilitated while in this complex (data not shown).
Control experiments were also performed in order to identify the individual
influence of copper, ascorbic acid and GTP on the production of •OH (Figure 14).

103

FIGURE 14
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Figure 14. EPR spectra of GTP and Cu(II) or L-ascorbic acid
A) to G) EPR spectra of the reaction of 1mM GTP, 10 µM Cu(II) sulfate, and 80 mM
DMPO in air-saturated PBS, pH=7.4 solution (without L-ascorbic acid). H) to L) EPR
spectra of the reaction of 1 mM GTP, 1 mM L-ascorbic acid, and 80 mM DMPO in airsaturated PBS, pH 7.4 solution (control). M) to P) EPR spectra of the reaction of 1mM Lascorbic acid, 10 µM Cu(II) sulfate, and 80 mM DMPO in air-saturated PBS, pH=7.4
solution (without GTP). All spectra were collected at room temperature (22 °C) and
plotted on the same scale (magnetic field and intensity of EPR) for comparison. EPR
conditions: receiver gain 5.02 x 104, modulation amplitude 1 G, time constant 163.84 ms,
frequency 9.687 GHz, power 20 mW and 1024 points resolution.
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In reactions without the reducing agent L-ascorbic acid, production of the
DMPO/•OH adduct starts at time points beginning at 10 minutes, rises slowly, and
persists for about 1 hour (Figure 14, spectra A to G). This demonstrates that the Lascorbic acid rapidly regenerates the Cu(II) species from Cu(I) formed during the
reaction, resulting in a major production of •OH in the beginning of the reaction (Figure
14, spectra 2C). In the absence of Cu(II) ions, there is no detectable •OH formed , and
the time course and amplitude of the ascorbyl radical is exactly as control reactions
containing L-ascorbic acid in PBS solution alone (Figure 14, spectra H to L and Fig. 1,
spectra A). Without the substrate GTP, we observed only the high-amplitude ascorbyl
radical peak due to recycling with the copper ions. This diminishes over time in a similar
fashion as reactions containing GTP (Figure 14, spectra M to P and Fig. 1, spectra D to
H).
With the aim of evaluating the effect of pH on •OH formation, we also analyzed
reactions at pH 7.0 and pH 5.7 (Figure 15).
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FIGURE 15

A
B

Control in PBS pH 7.0
Ascorbic acid 1mM

1 min
incubation

Ascorbyl radical

F

J

1 min

1 min

DMPO/ OH

C

4 min

D

12 min

E

20 min

G

4 min

O

1 min

K

4 min

P

4 min

Q

12 min

H

12 min

L

12 min

I

20 min

M

20 min

107

N

Control in PBS pH 5.7
Ascorbic acid 1mM

R

20 min

Figure 15. Effects of pH and reactant concentrations on free radical generation
A) and N) EPR spectra of 1 mM L-ascorbic and 80 mM DMPO in PBS, pH 7.0 (A) and
PBS, pH 5.7 (N); B) to E) EPR spectra of the reaction of 1 mM GTP, 1 mM L-ascorbic
acid, 10 µM Cu(II) sulfate, and 80 mM DMPO, in air-saturated PBS, pH 7.0 solution. F)
to I) EPR spectra of the reaction of 2 mM GTP, 1 mM L-ascorbic acid, 30 µM Cu(II)
sulfate, and 80 mM DMPO, in air-saturated PBS, pH=7.0 solution. J) to M) EPR spectra
of the reaction of 3 mM GTP, 1mM L-ascorbic acid, 40 µM Cu(II) sulfate, and 80 mM
DMPO, in air-saturated PBS, pH 7.0 solution. O) to P) EPR spectra of the reaction of 1
mM GTP, 1 mM L-ascorbic acid, 10 µM Cu(II) sulfate, and 80 mM DMPO, in airsaturated PBS, pH 5.7 solution. All spectra were collected at room temperature (22 °C)
and plotted on the same scale (magnetic field and intensity of EPR) for comparison. EPR
conditions: receiver gain 5.02 x 104, modulation amplitude 1 G, time constant 163.84 ms,
frequency 9.687 GHz, power 20 mW and 1024 points resolution.
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The production of both the ascorbyl radical and the DMPO/•OH adduct were
decreased by lowering the pH of the PBS in the reaction solution from control, pH 7.4, to
pH 7.0 and pH 5.7 (Figure 12, Figure 15, spectra A to E and N to R). We also evaluated
the effects of varying Cu(II) and GTP concentrations in solution on radical formation.
Spectra F to I and J to M are from reactions containing 1 mM L-ascorbic acid and 2 mM
GTP/30 µM Cu(II) sulfate and 3 mM GTP/40 µM Cu(II) sulfate respectively (Figure 15,
Spectra F to I and J to M). Increased concentrations of GTP and Cu(II) sulfate allowed
for the reactions to proceed faster as compared to reactions with 1mM GTP and 10 µM
Cu(II) sulfate, as demonstrated by the disappearance of the ascorbyl radical after 20
minutes (Figure 15, Spectra I and M).
Cu(II)-GTP complex
We performed direct EPR and UV-vis analysis of Cu(II) sulfate in PBS solution
and Cu(II) sulfate combined with GTP and detected changes in the Cu(II) center which
indicate a complexation of Cu(II) with GTP (Figure 16).
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FIGURE 16
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Figure 16. Direct EPR analysis of Cu(II) and GTP
A) EPR spectrum of 2 mM Cu(II) sulfate. B) EPR spectrum of 500 µM Cu(II) sulfate
with 2 mM of GTP. All solutions diluted in water, PBS, and 5% glycerol. EPR
conducted at 77K.
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EPR spectra of Cu(II) sulfate in PBS solution and Cu(II) sulfate combined with GTP
were collected from frozen solutions of each and showed a characteristic profile of an
axial environment around the Cu(II) center, as shown by the relationship of the electron
g-factors (g) g// > g⊥ (Figure 16, A-B). However, it was observed that a great structural
change on the Cu(II) center took place in the presence of GTP in solution. Specifically,
the EPR hyperfine parameters A//, g// and g⊥ changed from 132 x 10-4 cm-1, 2.42 and
2.1217 respectively, in an aqueous solution of Cu(II) sulfate, to 149 x 10-4 cm-1, 2.37 and
2.0736 respectively, in solution where GTP was present (Figure 16, A-B). Additionally,
electronic spectra of Cu(II) sulfate alone and in the presence of GTP carried out under the
same conditions of EPR analysis, showed a slight change on d-d absorption band (data
not shown).
Oxygen consumption
To confirm the participation of molecular oxygen in the GTP oxidation we
monitored oxygen consumption in reaction of GTP, Cu(II) sulfate, and L-ascorbic acid
using a Clark electrode. Figure 17 shows representative curves of O2 consumption when
either Cu(II) sulfate or Cu(II) imine are added as the Cu(II) catalysts in solutions
containing GTP and L-ascorbic acid. Oxygen consumption over time was very similar
for the two Cu(II) compounds which indicates that Cu(II) sulfate acts as a stable complex
in solutions with GTP.
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FIGURE 17
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Figure 17. Oxygen consumption by GTP, Cu(II), and L-ascorbic acid
Oxygen measurements using a Clark electrode of the reaction of 1 mM GTP, 1 mM Lascorbic acid, 10 µM Cu(II) sulfate () or Cu(Imine) (), in air-saturated PBS, pH 7.4
solution in a total cell volume of 1.5 mL at (22.0 ± 0.2) °C.
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Total consumption of O2 was observed within approximately 20 minutes. This
corroborates the EPR spin trapping results presented in Figure 12 which shows that the
DMPO/•OH adduct formed during the reaction is undetectable and the ascorbyl radical is
at background levels after 20 minutes.
Oxo8GTP production
In order to verify and quantify the levels of oxo8GTP produced by the copper/GTP/Lascorbic acid system, we utilized HPLC-EC and MALDI-TOF. Figure 18 includes
representative chromatograms and spectra from four-hour incubations at 37oC of GTP
under control conditions (1 mM L-ascorbic acid), incubations of GTP with10 µM Cu(II)
sulfate only, and incubations of GTP with both L-ascorbic acid and Cu(II) sulfate.
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FIGURE 18
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Figure 18. Oxo8GTP formation analysis by HPLC-EC and MALDI-TOF
A) and D) are HPLC-EC chromatogram and MALDI-TOF spectra of oxo8G (reported as
oxo8GTP, see Methods) and GTP respectively, in a four-hour incubation of 1 mM GTP
and 1 mM L-ascorbic acid at 37oC. Inset of D) is from a standard solution containing 1:1
GTP:Oxo8GTP. B) and E) is a four-hour incubation of 1mM GTP and 200 µM Cu(II)
sulfate at 37oC. C) and F) is a four-hour incubation of 1mM GTP, 1mM L-ascorbic acid,
and 10 µM Cu(II) sulfate at 37oC. HPLC-EC chromatograms show traces collected at
250 mV EC channel. MALDI-TOF spectra are normalized to % Intensity of signal and
baselines were corrected for noise.
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The highest levels of oxo8GTP, approximately 430 picomoles, were produced with a
four-hour incubation of 1 mM GTP with both 1 mM L-ascorbic acid and 10 µM Cu(II)
sulfate (Figure 18C and 19C). L-ascorbic acid alone was able to oxidize GTP due to the
presence of the ascorbyl radical confirmed by EPR analysis although the oxo8GTP
produced was four times lower than incubations that included 10 µM Cu(II) sulfate
(Figure 18A and 19C).
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FIGURE 19
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Figure 19. Oxo8GTP in GTP, Cu(II), L-ascorbic acid and Aβ 1-42 reactions
A) Oxo8GTP levels quantified by HPLC-EC in one-hour incubations of 1mM GTP and
increasing concentrations of L-ascorbic acid. B) Oxo8GTP levels quantified by HPLCEC in four-hour incubations of 1 mM GTP, 1 mM L-ascorbic acid, and increasing
concentrations of Cu(II) sulfate. C) Oxo8GTP levels quantified by HPLC-EC in fourhour incubations of 1 mM GTP and 1 mM L-ascorbic acid, 200 µM Cu(II) sulfate, 1mM
L-ascorbic acid/ 10 µM Cu(II) sulfate, 100 nM Aβ1-42, and 10 µM Cu(II) sulfate/100 nM
Aβ1-42 at 37oC. Data represent mean ± SEM. n= 2-9. * p< 0.05 applying a one-way
ANOVA with Newman-Keuls Multiple Comparison Test post-hoc analysis.
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However, oxo8GTP is undetectable in incubations of GTP with10 µM Cu(II) sulfate
alone in the µAmpere (µA) scale used to report oxo8GTP under control and 1 mMascorbic acid/10 µM Cu(II) sulfate conditions (Figure 8B). When quantified using the
nanoampere (nA) scale, oxo8GTP levels in incubations without 1 mM L-ascorbic acid are
detectable although three orders of magnitude lower than those that include the reductant
in the presence of 10 µM Cu(II) sulfate (Figure 19C). These results confirm the EPR
analysis of GTP incubations where the highest levels of the most oxidizing radical •OH
were observed in reactions that included both L-ascorbic acid and copper. MALDI-TOF
spectra confirmed the presence of oxo8GTP in these four-hour incubations (Figure 18, D
to F). Mass to charge (m/z) ratios for standard mixtures of GTP and oxo8GTP were
522.20 and 538.33 respectively, which were also detected in our incubations of GTP
under control (1 mM L-ascorbic acid) and 1 mM L-ascorbic acid/10 µM Cu (II) sulfate
conditions.
L-ascorbic acid alone was able to increase oxo8GTP levels in a dose-dependent
manner during one-hour incubations at 37oC with the highest oxidation seen at 1 mM and
a decrease in oxo8GTP observed at concentrations of 10 mM (Figure 19A). Increasing
concentrations of Cu(II) sulfate in the presence of 1 mM L-ascorbic acid also dosedependently increased oxo8GTP levels reaching the highest values at 10 µM with no
additional oxidation seen at 100 µM (Figure 19B).
To emphasize the specificity of our oxo8GTP-generating system, we included
another endogenous biological oxidant, the aggregated peptide found in the senile
plaques of AD brains, amyloid beta peptide (Aβ1-42). Our results included in Figure 19
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indicate that Aβ1-42 alone is not capable of producing ROS at a level that oxidizes GTP to
a detectable degree.
Mechanism proposed
The results presented herein indicate a mechanism involving ROS and the
ascorbyl radical in the oxidation of GTP by copper. As shown in the proposed
mechanism in Figure 20, key factors in this oxidative modification of GTP is the
requirement for oxygen and the complexation of Cu(II) with GTP.
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FIGURE 20
Proposed mechanism of GTP oxidation by Cu(II) ions
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The •OH produced in our solutions, via Fenton reactions involving Cu(II) is likely
responsible for the production of oxo8GTP because of its high oxidation potential (Eº =
2.31 V, pH 7.0) (Halliwell and Gutteridge 1986). In the first step of our proposed
mechanism, the Cu(II) ion forms a complex with GTP and in step 2, is reduced to Cu(I)GTP via electron transfer from the oxidation of ascorbic acid to the ascorbyl radical.
This is followed by step 3 in which the Cu(I)-GTP reacts with molecular oxygen present
in the solution to generate O2-• by electron transfer, and Cu(II)-GTP is regenerated and
enters the cycle to produce another ascorbyl radical. The generated O2-• is subsequently
reduced (E º = 0.94 V) in the presence of the ascorbyl radical to H2O2 in step 4. The
ascorbyl radical is also converted back to ascorbate in this step (E º = 0.28 V). The
reaction of the ascorbyl radical and O2-•, generating ascorbate and H2O2 has a second
order rate constant of 2.3 x 108 M-1 s-1 (Scarpa, Stevanato et al. 1983). The other
important reaction that can happen in this system is the oxidation of ascorbic acid by O2-•
which proceeds with a second order rate constant of about 2.7 x 105 M-1 s-1 (Nishikimi
1975). Thus, the ascorbyl radical produced in the first step of this reaction acts as an
important agent in the reduction of O2-• to H2O2 which enters the Fenton reaction with
Cu(I)-GTP in step 5 to produce •OH. Finally, this generated •OH goes on to oxidize GTP
to oxo8GTP in step 6. The reaction stops when available oxygen is consumed in the
reactions or all available GTP is oxidized. Based on the results presented in this work,
we propose a •OH-mediated mechanism for GTP oxidation by Cu(II) in the presence of
L-ascorbic acid.
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Discussion
We have previously demonstrated that the Cu/L-ascorbic acid system leads to the
formation of the oxo8GTP cell-free preparation as well as in cells in culture (Bolin and
Cardozo-Pelaez 2007). It has been proposed that oxidation of the G moiety is mainly due
to attack by •OH (Breen and Murphy 1995). In order to verify the chemical generation of
•OH and consequent oxidation of GTP by Cu(II)-GTP complexes, we investigated free
radical production by the copper/GTP/L-ascorbic acid system. In general, these EPR
spin trapping experiments confirmed the production of •OH and the ascorbyl radical in
reactions containing GTP, Cu(II), and ascorbate (Figure 12). The results also suggest
that copper(II) catalyzes the formation of •OH while complexed, stabilizing the copper
ion. The empirical ratio g///A// is frequently used to evaluate tetrahedral distortions in
tetragonal structures of Cu(II) compounds. A ratio g///A// close to 100 cm indicates a
square planar or tetragonal structure around the Cu(II) ion, and values from 175 to 250
cm are indicative of a distorted tetrahedral symmetry (Muller, Felix et al. 1995). Based
on this designation, our data revealed a change to a more tetragonal structure when Cu(II)
is combined with GTP in solution and strongly suggests the complexation of Cu(II) with
GTP. The maximum wavelength for Cu(II) sulfate in aqueous PBS solution decreased
from 750 nm to 830 nm in presence of GTP thus corroborating the changes on the Cu(II)
center observed by EPR. The formation of a Cu(II) complex with GTP favors the
formation of a more efficient catalyst for the observed oxidation of GTP, by facilitating
Cu(II)/Cu(I) redox potential changes (Azzellini, Bagatin et al. 2006). When a redox
active metal like copper is bound to a biological molecule such as GTP, known to be
susceptible to oxidation, the oxidative-reduction reaction between ion states of the metal
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can generate ROS locally that modify the molecule to which the metal is bound most
efficiently. Our finding that L-ascorbic acid alone generates detectable levels of the
ascorbyl radical and consequently leads to the oxidation of GTP in the absence of copper
is not unsual. The dual-role of L-ascorbic acid as an oxidant at lower concentrations and
antioxidant at higher concentrations has been previously reported and is due to the
decrease in the rate of antioxidant reactions by ascorbate at low concentrations as
compared to the rate of radical chain reactions initiated by catalytic metals such as copper
(Buettner and Jurkiewicz 1996).
The •OH-producing system of GTP/1 mM L-ascorbic acid/ 10 µM Cu(II) sulfate
presented in this study has been shown to generate significant levels of oxo8GTP in cell
culture (Bolin and Cardozo-Pelaez 2007). Interestingly, the increase in the percent of
oxo8GTP produced relative to GTP in HEK 293T cells exposed to 1 mM L-ascorbic acid/
10 µM Cu(II) sulfate as compared to control is nearly twice as high as that observed in
cell-free preparations of GTP like those reported here. This is likely due to higher
availability of oxygen for this •OH-producing system in a respiring cell as compared to a
cell-free, closed reaction with high oxygen demand but limited oxygen supply.
In order to evaluate this mechanism of oxidation in regards to a disease pathology
known to be associated with oxidative stress, we decided to include the aggregated
peptide Aβ1-42 found in senile AD plaques (Gaggelli, Kozlowski et al. 2006). There has
been some debate as to whether aggregated Aβ1-42 can spontaneously produce ROS
(Hensley, Carney et al. 1994; Turnbull, Tabner et al. 2001). Our results indicate that Aβ142 alone

is not capable of producing ROS at a level that oxidizes GTP to a detectable

degree. This finding lends support to the hypothesis that Fenton-reactive metals such as

126

copper that from complexes with these senile plaques, at concentrations estimated to be
as high as 400 µM in AD brain, and copper-complexing biomolecules such as GTP are
likely the source of ROS which cause measurable oxidative modification to biomolecules
in pathologies such as AD (Lovell, Robertson et al. 1998; Huang, Atwood et al. 1999;
Huang, Cuajungco et al. 1999; Dikalov, Vitek et al. 2004).
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Conclusions
In this study we report that GTP oxidation by copper is promoted by the
production of ROS (summarized in Figure 20). Complexation of Cu(II) with GTP is an
integral step in this mechanism of oxidation to produce oxo8GTP as is the availability of
a cellular reductant such as L-ascorbic acid and oxygen.

An endogenous environment

that fulfills these oxidative requirements is found in the brains of patients with
neurodegenerative disease pathologies such as AD where copper, L-ascorbic acid, GTP,
and oxygen are all within the range used in the cell-free experiments presented herein.
Insight into the mechanism of GTP oxidation could lend important clues as to how
oxidative damage from aging or disease pathologies might impair neuronal cell processes
necessary for proper brain function. The influence of pH on the level of the generated
radicals suggest that H2O2 is involved in the •OH production. This H2O2 is likely formed
by the reaction of O2•-, generated initially by copper in the presence of O2, with available
hydrogen in the reaction milieu (Fig. 20).
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CHAPTER THREE
Characterization of Oxidized Guanosine 5’-Triphosphate (oxo8GTP) as a viable
inhibitor of soluble guanylyl cyclase (sGC)
Abstract
We have recently characterized oxidation of guanosine (G) in the nucleotide
triphosphate pool, yielding oxidized guanosine 5’-triphoshate (oxo8GTP), is an important
biomarker of oxidative stress. Oxo8GTP has been shown to precede oxidation to G
incorporated into DNA and modulate cell processes such as G-protein signaling and RNA
synthesis. This study demonstrates significant induction of oxo8GTP in cell-free
preparation as well as in PC12 cells exposed to physiologically relevant oxidative
conditions generated with 10 µM copper sulphate and 1 mM L-Ascorbic Acid (Cu/Asc).
We also present data identifying soluble guanyly cyclase (sGC) as important target of
oxo8GTP using purified sGC and endogenous sGC in PC12 cells. Oxo8GTP is
characterized as a competitive inhibitor of sGC and evidence is presented of Cu/Asc
causing elevations in oxo8GTP significant enough to result in a reduction of the sGC
product cGMP by as much as half in pure sGC and PC12 cells. GTP is protected from
oxidation in the presence of reduced glutathione and this subsequently rescues sGC
activity. This suggests that oxo8GTP is produced by free radicals in vivo and can have
significant impact on cell functions regulated by sGC activity such as synaptic plasticity
in the central nervous system. Alterations in copper homeostasis and oxidative stress
have been implicated in several neurodegenerative disorders including Alzheimer’s,
Prion, and Parkinson’s diseases as well as Amyotrophic Lateral Sclerosis. Thus, it is
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possible that neuronal deficiencies in such disorders might be due to oxidation of the
GTP pool and the ensuing effects in neuronal function.
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Introduction
Oxidative stress has been implicated in the onset and development of several
pathological processes including cancer and age-related neurodegenerative diseases such
as Alzheimer’s Disease (AD) and Parkinson’s Disease (Hollstein, Sidransky et al. 1991;
Sanchez-Ramos 1994; Alam, Jenner et al. 1997; Gabbita, Lovell et al. 1998; Wang,
Xiong et al. 2005). Oxidative stress is often accomplished by probing cellular DNA for
modified guanine, reported as 8-oxo-2’-deoxyguanosine (oxo82dG), a cellular biomarker
(Dizdaroglu, Jaruga et al. 2002; Proteggente, England et al. 2002; Chiou, Chang et al.
2003). However, the percent of oxo8dG relative to unmodified 2’-deoxyguanosine (2dG) in DNA in tissues from pathologies such as Alzheimer’s Disease and Parkinson’s
Disease is quite low, as little as 0.002 to 1% (Te Koppele, Lucassen et al. 1996; Alam,
Jenner et al. 1997; Gabbita, Lovell et al. 1998). This implies that nuclear guanosine (G)
moieties found in DNA may not be the best place to quantify oxidative insult. Increases
in oxo8dG levels in DNA can also occur after hydroxyl radical (OH. ) attack on the
cytosolic pool of G incorporated into 2-dG 5’- triphosphate (dGTP) or guanosine 5’triphosphate (GTP). This oxidative modification produces the respective oxidized 2-dG
and G triphosphate adducts, oxo8dGTP and oxo8GTP (Hayakawa, Taketomi et al. 1995).
We have recently validated a novel method to measure oxidized guanosine triphosphate
moieties using HPLC with electrochemical (EC) detection (Bolin and Cardozo-Pelaez
2007). Using this method, we have shown that the percent of cytosolic oxo8GTP relative
to GTP in human embryo kidney 293T (HEK 293T) cells under normal growth
conditions was greater than 400 times the percent of oxo82dG to 2-dG in nuclear DNA
under the conditions (Bolin and Cardozo-Pelaez 2007).
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GTP participates in several critical physiological functions including RNA
synthesis, cell signaling through activation of GTP-binding proteins, as well as the
production of the second messenger cyclic guanosine monophosphate (cGMP) (Waldman
and Murad 1987; Jayaram, Cooney et al. 1999; Metaye, Gibelin et al. 2005). Recent
studies have shown that addition of oxo8GTP to in vitro transcription reactions reduces
the total amount of mRNA synthesized as well as increasing the number of mutations in
the mRNA (Kamiya, Suzuki et al. 2007). Additionally, oxo8GTP was shown to increase
the activity of the GTP-binding protein Ras as well as downstream activators of the RasERK pathway in HEK293T cells while the opposite effect was observed with the GTPbinding protein Rac1 (Yoon, Hyun et al. 2005). Given these reported effects of oxo8GTP
and our verification of its formation in cells, we opted to determine the role of oxo8GTP
on the activity of soluble guanylyl cyclase (sGC) [E.C. 4.6.1.2.]. sGC facilitates the
conversion of GTP to cGMP, a pathway important for a range of physiological processes
such as vasodilation, platelet aggregation, and neurotransmission (Moncada, Palmer et al.
1991). Alterations in the capacity of sGC to respond to NO, level of expression of sGC,
as well as sGC activity have been associated with physiological deficiencies that may
play a role in the pathologies of a variety of disorders including cardiovascular disease
and neurological diseases including Alzheimer’s Disease (AD) and Creutzfeldt-Jakob
disease (Bonkale, Winblad et al. 1995; Baltrons, Pifarre et al. 2004; Puzzo, Vitolo et al.
2005; Moncada and Higgs 2006). Despite evidence of oxidative stress as a major player
in these pathologies and evidence of GTP being a target for free radical attack, there have
been no studies aimed at identifying the consequences of oxo8GTP on sGC activity
(Gaggelli, Kozlowski et al. 2006). We hypothesize that the GTP pool is vulnerable to
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conditions of oxidative stress and formation of oxo8GTP will impact cellular function,
specifically the activity of sGC. We present evidence of oxo8GTP as a viable inhibitor of
purified sGC and endogenous sGC in PC12 cells. Our results support evidence of
oxo8GTP being a critical cellular biomarker of oxidative stress with deleterious biological
consequences.
The goal of this study was to investigate the effects of oxo8GTP on sGC activity
in vitro and in rat pheochromocytoma (PC12) cells. We present evidence of oxo8GTP as
a viable inhibitor of purified sGC as well as endogenous sGC in PC12 cells. Our results
support evidence of oxo8GTP being a critical cellular biomarker of oxidative stress with
deleterious biological consequences. Several synthetic stimulators and inhibitors of sGC
have been used for experimental and therapeutic investigations although the effects of the
endogenous product of GTP oxidation, oxo8GTP, on sGC activity has never been
evaluated until now (Gruetter, Kadowitz et al. 1981; Garthwaite, Southam et al. 1995;
Schrammel, Behrends et al. 1996; Olesen, Drejer et al. 1998; Hobbs 2002).
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Materials and Methods
Materials
All reagents were purchased from Sigma-Aldrich (St. Louis, MO), unless otherwise
indicated. 8-oxoguanosine-5’-triphosphate (oxo8GTP) was purchased from TriLink
Biotechnologies (San Diego, CA). 8-hydroxy guanosine (oxo8G) was obtained from
Cayman Chemical (Ann Arbor, MI). Soluble guanylyl cyclase (sGC) isolated from
bovine lung, DEA NONOate (DEA/NO), and 3-isobutyl-1-methylxanthine (IBMX) were
purchased from Alexis Biochemicals (Lausen, Switzerland). Ultrapure water was
obtained from a Milli-Q UF-Plus apparatus (Millipore, Billerica, MA).
cGMP Deterimination by HPLC-EC
cGMP was resolved by HPLC with a reverse phase YMC basic column (4.6 x 150
mm; particle size 3-micron) (YMC Inc., Wilmington, NC) and quantified using a
CoulArray electrochemical detection system (ESA, Inc., Chelmsford, MA). An isocratic
mobile phase consisting of 100 mM sodium acetate, pH 5.2, 4% Methanol (HPLC Grade)
diluted in water polished with C18 Sep-Pak cartridges (Waters Corp., Milford, MA) was
utilized to elute cGMP from the column. The mobile phase was filtered using 0.2 µm
nylon filters and degassed by sonication before use with the HPLC. Potentials of the
twelve coulometric analytical cells of the CoulArray system, placed in series, were as
follows: 50, 125, 175, 200, 250, 380, 500, 700, 785, 850, 890, 900 mV. Data were
recorded, analyzed, and stored using CoulArray for Windows data analysis software
(ESA Inc., Chelmsford, MA). A calibration curve was generated from standards of
cGMP ranging from 5 nanograms (13.6 picomoles) to 1 milligram (2.7 nanomoles).
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Elution of the cGMP analyte was monitored in the 700, 785, and 850 mV channels and
injected amounts were plotted relative to the sum of the peak areas.
Measurement sGC activity in cell-free and PC12 extract samples
5 ng of purified sGC from bovine lung was incubated with 1 mM GTP and
stimulated with increasing concentrations of DEA/NO (0.001 µM to 100 µM diluted in
ice-cold 10 mM NaOH) in buffer containing 3 mM MgCl2, 0.5 g/L BSA, 50 mM TEA, 3
mM DTT, pH 7.4 at 37oC for 10 minutes. The reaction was stopped by placing on ice
and immediately adding 0.5 N HClO4 to a final concentration of 0.05 N HClO4. Samples
were mixed and centrifuged at 14,000 x g at 4oC for 15 minutes. Supernatants were then
subjected to 0.45 µm filtration and 10 µL was then immediately injected into the HPLCEC.
PC12 cells were seated at a density of 5-7 x 107 cells per plate in 10 mL of RPMI
1640 medium containing 5% fetal bovine serum (FBS), 10% horse serum (HS), 2 mM Lglutamine, 1mM sodium pyruvate, 25 units penicillin G, and 25 µL/mL of streptomyocin.
Cells were grown until 80-90% confluent (about 4 days) on collagen coated 100 mM
petri dishes maintained at 37oC, 5% CO2, and 95% air atmosphere. Following a 10
minute incubation at 37oC with media containing 1mM IBMX, cells are incubated with
increasing concentrations of DEA/NO (0.001 µM to 100 µM ) at 37oC for 10 minutes.
Prior to cGMP extraction, these PC12 cells were assessed for viability using the trypan
blue exclusion method. The media was then replaced with 5 mL of ice-cold phosphatebuffered saline (PBS) containing 1mM IBMX prior to collecting cells and centrifuging at
1500 rpm at 4oC for 5 minutes. The cells were then washed with 300 µL of ice-cold
PBS, sonicated, mixed, and centrifuged at 14,000 x g at 4oC for 15 minutes. A 10 µL
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aliquot was set aside for Bradford protein analysis and 30 µL of 0.5 N HClO4 was then
added to remaining supernatant and centrifuged at 14, 000 x g, 4oC for 15 minutes. After
0.45 µm filtering, the 27 µL of supernatant was immediately injected into the HPLC-EC.
cGMP was quantified in each sample based on calibration curves generated from known
quantities of cGMP.
Measurement of GTP and Oxo8GTP
GTP and Oxo8GTP were isolated and quantified using HPLC-EC with preparative
dephosphorylation as described previously (Bolin and Cardozo-Pelaez 2007). Briefly,
PC12 cells grown under standard conditions described above were exposed to normal
media (control) or media containing 1mM L-ascorbic acid and 10 µM copper sulfate
(Cu/Asc) for 4 hours. After washing three times with ice-cold PBS, cells were collected
in 300 µL of PBS. Following centrifugation, protein was precipitated using 30 µL of
60% Trichloroacetic Acid (TCA), vortex-mixed for 20s, placed in an ice-bath for 10
minutes, and vortex-mixed again for 20s. Cell extracts were then centrifuged at 13,000
rpm for 10 minutes at 4oC. The resulting supernatant was neutralized to pH 6.0 with a
solution containing 3 M KOH and 3 M KHCO3. GTP and oxo8GTP were then
dephosphorylated to their respective nucleosides guanosine (G) and 8-oxoguanosine
(oxo8G) for detection via HPLC-EC. On ice, 25 Units of alkaline phosphatase (dissolved
in Tris-HCl pH 8.0), 1.8 mM sodium acetate, and 100mM Tris-HCl, were added to 30µL
of sample in total volume of 60 µL. After incubation at 37oC for 1 hour, the
dephosphorylation reaction was stopped by placing on ice. This was followed by
filtering through Ultrafree-MC (30-kD) tubes (Millipore Corp., Bedford, MA). Detection
of the generated nucleosides (G and oxo8G) was carried out by injecting 27 µL of the
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filtrate into the HPLC-EC using exactly the same HPLC-EC conditions described above.
Guanosine elution was monitored in the 700, 785, and 850 mV channels and injected
amounts were graphed relative to the sum of peak areas. Oxo8G was monitored in the
250 mV channel and injected amounts were graphed relative to peak area. Calibration
curves for G and Oxo8G were generated from known quantities of each analyte ranging
from 120 pmoles to 1.92 nmoles for G and 2.4 pmoles and 38.4 pmoles for oxo8G. G
and oxo8G quantified in samples were reported as GTP and oxo8GTP respectively.
Statistical Analysis
All data were analyzed using Prism GraphPad 4.0 software (Graph pad Software
Inc., San Diego, CA). Calibration curve parameters for each of the analytes were
obtained by linear regression analysis. Double reciprocal kinetic plots (LineweaverBurke) were analyzed using linear regression analysis. An unpaired t-test was performed
on GTP, oxo8GTP, and cGMP values collected from PC12 cells exposed to Cu/Asc;
values denoted with an asterisk are significantly different from their corresponding
controls (P < 0.05). A one-way ANOVA with Newman-Keuls Multiple Comparison Test
post-hoc analysis was performed on in vitro GTP oxidation experiments with and without
GSH; values denoted with an asterisk are significantly different from their corresponding
controls (P < 0.05).
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Results
Assay for sGC Activity Using HPLC-EC
Previous in vitro and in vivo studies of sGC activity have primarily utilized
radioimmunoassay for detection of cGMP although HPLC methods have been previously
presented (Yamamoto, Shimizu et al. 1984; Goossens, Leroux et al. 1994; Yonekura,
Iwasaki et al. 1994; Pietta, Mauri et al. 1997; Seya, Furukawa et al. 1999; Diaz Enrich,
Villamarin et al. 2000; Soda, Ohba et al. 2001). In order to measure sGC activity with
the highest specificity and sensitivity, we developed a chromatographic analysis protocol
employing HPLC-EC, to detect cGMP and determine sGC activity in cell-free
preparations with purified sGC and in cell culture, using PC12 cells. sGC activity was
defined as the amount of cGMP formed in a 10 minute reaction at 37oC after the addition
of DEA/NO to activate sGC. Figure 21A was obtained by injection of a standard
containing 40 ng (108.9 pmoles) of purified cGMP eluting in the 785, 850, and 890 mV
channels at approximately 6.0 minutes. Figure 21B demonstrates the linearity of the EC
detector at these specific voltages for cGMP. The response was linear up to 4 milligrams
(10.9 nanomoles) of injected cGMP with a minimum detection limit of 5 picograms (13.6
femtomoles).
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FIGURE 21
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Figure 21. Chromatographic profile for cGMP
cGMP detected and quantified based on the sum of peak areas of channels set at 785,
850, and 890 mV (A). Calibration curve showing the dynamic range of cGMP from 5 ng
to 1 µg (B).
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To test the validity of this approach to determine sGC activity, we stimulated purified
sGC and PC12 cells with the NO donor DEA/NO. Figure 22A demonstrates that levels
of cGMP detected using this method increased in a sigmoidal fashion with increasing
concentrations of the NO donor DEA/NO using purified, cell–free sGC. cGMP was
produced in a dose-dependent manner with maximal stimulation at 10 µM DEA/NO and
an EC50 of 266 nM, values similar to previously reported values of sGC activity
measured in cell-free preparations by radioimmunoassay (Bellamy, Griffiths et al. 2002).
Figure 22B demonstrates that exposure of PC12 cells yields a similar concentrationresponse with increasing concentrations of DEA/NO with maximal stimulation at 50 µM
DEA/NO and an EC50 of 5.7 µM. Addition of 50 µM DEA/NO to PC12 cells for 10
minutes resulted in an approximately 10-fold increase in intracellular cGMP levels ( 4.2 ±
0.37 nmoles/ mg total protein). This demonstrates that under our experimental
conditions, PC12 cells produce a strong increase of detectable cGMP after NO
stimulation.
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FIGURE 22
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Figure 22. sGC activity with increasing NO concentrations
cGMP levels in purified sGC(A) and cellular extracts from PC12 cells (B). Data are
expressed as the mean amount of product (cGMP) ± SEM (n = 3-6) normalized to the
maximal response observed in each experiment. x-axis is (log10 scale).
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Kinetic Characterization of Oxo8GTP as an Inhibitor of sGC
In order to determine the role of oxo8GTP in the activity of sGC, we performed kinetic
studies of sGC activity in presence of increasing levels of oxo8GTP. Oxo8GTP was
found to inhibit the conversion of GTP to cGMP at low and high concentrations of GTP.
Oxo8GTP was added to incubations of purified sGC and stimulated with 10 µM DEA/NO
and increasing concentrations of GTP (0.5 µM to 2 mM). Figure 23A shows cGMP
levels produced by sGC after stimulation with DEA/NO (10 µM) in presence of 500 µM
or 50 µM GTP with increasing levels of oxo8GTP.
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FIGURE 23

147

Figure 23. Inhibition of sGC by oxo8GTP
Oxo8GTP-induced inhibition was determined in DEA/NO-stimulated, purified sGC in the
presence of two different concentrations of the substrate (GTP) (A) and significant
reduction in initial velocity (Vo) is demonstrated with as low as 100 nM oxo8GTP (A,
inset). Data represented as 1/velocity vs. 1/[GTP] indicate a noncompetitive, mixed type
of inhibition by oxo8GTP (B) as shown by a decreasing maximal velocity (Vmax) with
increasing oxo8GTP concentrations (B, inset). Data are expressed as the means ± SEM (n
= 3, * p < 0.05).
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At both concentrations of GTP, oxo8GTP was shown to inhibit sGC at concentrations
greater than 100 µM. Values for IC50 were calculated to be 1.8mM for 500 µM GTP and
288 µM for 50 µM GTP. Despite the high IC50 values, inhibition of sGC incubated in the
presence of 50 µM GTP was significant at levels of oxo8GTP as low as 100 nM (Figure
23A, inset). Addition of as much as 100 µM DEA/NO to our cell-free sGC preparations
with oxo8GTP was ineffective at overcoming inhibition of the enzyme (Figure 24).
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FIGURE 24
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Figure 24. Effect of NO on sGC inhibition by oxo8GTP
sGC activity, as assessed by total amount of cGMP product formed (ng), in reactions
containing GTP and increasing concentrations of DEA/NO with or without oxo8GTP.
Data are expressed as means ± SEM (n = 3).
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To identify the nature of the inhibition of sGC by oxo8GTP, we determined MichaelisMenten kinetic characteristics of the enzyme by plotting the substrate (GTP) versus the
initial velocity (Vo). The percent conversion of substrate (GTP) to product (cGMP) was
found to be between 0.1 and 16%, the production of cGMP was linear with time, purified
sGC was stable during the 10 minute reaction period and therefore the Michaelis-Menten
model is assumed (Marangoni 2003). We found the Michaelis constant (Km) for GTP
with purified sGC stimulated with 10 µM DEA/NO to be 24 µM, similar to previously
published studies using cell-free, human sGC and synthetic NO donors (Table 8, Figure
23B) (Lee, Martin et al. 2000). The addition of 50 µM or 250 µM oxo8GTP resulted in a
very small change from Km values calculated in sGC stimulated with 10 µM DEA/NO
(Table 8, Figure 23B).
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Table 8. Kinetic parameters of sGC inhibition by oxo8GTP
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However, the maximum reaction velocity (Vmax) of sGC decreased from 683.06 µM GTP
without inhibitor present to 346.14 µM GTP with 250 µM oxo8GTP included in the
reactions (Table 8, Figure 23B). The transformation of the same data into doublereciprocal plots at increasing concentrations of oxo8GTP indicate that oxo8GTP behaves
as a noncompetitive, mixed type inhibitor of sGC (Figure 23B, inset).
Oxidative stress induces oxo8GTP formation and sGC inhibition reversible by GSH
The direct addition of oxo8GTP tells us very little of the consequences linked to its
formation in biological systems. We have previously shown that a mixture of L-ascorbic
acid (1 mM) and Copper Sulfate (10 µM) are sufficient to induce oxo8GTP levels in cellfree reactions of GTP as well as in cell culture (Bolin and Cardozo-Pelaez 2007). To
further investigate if the free radical-induced formation of oxo8GTP can result in
biological levels that decrease sGC activity, we exposed GTP to the Cu/As mixture
before assessment of sGC activity. Figure 25A indicates that a four hour exposure of
pure GTP to Cu/Asc results in a increase in oxo8GTP that is three orders of magnitude
higher than control.
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FIGURE 25
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Figure 25. Induction of Oxo8GTP with Cu/Asc and the effect of GSH
Increase in cell-free oxo8GTP formation after incubation of GTP (inset) with Cu/Asc
(black bars) as compared to control (white bar) conditions and the reduction of this
oxidation by equimolar amount of GSH present in the incubations (A). Resulting
reduction in DEA/NO-stimulated purified sGC activity with 1mM of GTP from (A) preincubated with Cu/Asc (black bars) as compared to control (white bars) and the rescue of
this activity with GTP protected from oxidation by the presence of equimolar amounts of
GSH (B) during four-hour incubations reported in (A). Data expressed as the means ±
SEM (n =3, * p < 0.05 compared to control, # p<0.05 compared to Cu/Asc without GSH).
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It should be noted that incubations of pure GTP with L-ascorbic acid alone also shows a
statistically significant increase in oxo8GTP which is not due to trace metal contaminants,
used as pre-treatment of all buffers with Chelex resin had no effect on oxo8GTP levels
(Figure 26).
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FIGURE 26

158

Figure 26. Levels of oxo8GTP induced Cu and Asc independently
Amount of oxo8GTP formed (pmoles) in four-hour incubations at 37oC of 1mM pure
GTP, 1 mM GTP exposed to 200 µM copper sulfate or 1mM L-ascorbic acid, and 1mM
GTP exposed to 1 mM L-ascorbic acid in Chelex resin-treated buffers. Data are
expressed as means ± SEM (n=2-6, * p < 0.05 as compared to pure GTP).
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However as much as 200 µM copper sulfate does not increase oxo8GTP above the small
amounts produced in a four-hour incubation of pure GTP at 37oC (Figure 26). This
oxidation of GTP by Cu/Asc in combination also results in significantly reduced levels of
recovered GTP from 11.295 ± 0.102 to 8.518 ± 0.135 nmoles (Figure 25A, inset). sGC
reactions using 1 mM of this GTP pre-incubated with Cu/Asc, exhibited a significant
reduction in 100 nM DEA/NO-stimulated sGC activity as compared to control reactions
with unmodified GTP (Figure 25B). Incubation of purified sGC with Cu/Asc prior to
stimulation with as much as 1 µM DEA/NO did not show any reduction in activity
demonstrating that there is no direct effect of these oxidation conditions on sGC and
inhibition is likely due to elevations in cellular oxo8GTP (Figure 27).
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FIGURE 27
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Figure 27. sGC activity of purified sGC incubated with Cu/Asc
sGC activity, as assessed by total amount of cGMP product formed (ng), in purified sGC
incubated with Cu/Asc (black bars) or PBS (white bars) before exposure to 1 mM GTP
and stimulation with 1, 100, or 1000 nM DEA/NO. Data are expressed as means ± SEM
(n=2).
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It has been previously demonstrated that either Cu or Ascorbate alone can inhibit sGC
and this inhibition is prevented by the antioxidant reduced glutathione (GSH)
(Schrammel, Koesling et al. 1996; Schrammel, Koesling et al. 2000). Addition of
equimolar amounts of GSH to GTP before incubation with Cu/Asc significantly reduced
the levels of oxo8GTP formed and rescued sGC activity (Figure 25). GSH had no effect
on recovered GTP (Figure 25).
Increase in Oxo8GTP in PC12 Cells Exposed to Cu/Asc: Effect on cellular sGC
Despite these previous results and other reported effects of oxo8GTP, little is known of its
role in cellular systems. We have recently shown that the known ROS producing system
of 10 µM copper sulfate and 1 mM L-ascorbic acid (Cu/Asc) is capable of increasing
oxo8GTP in cell-free incubations of GTP alone as well as in HEK 293T cells (Figure 5A)
(Biaglow, Held et al. 1996; Bolin and Cardozo-Pelaez 2007). In order to determine
whether a similar challenge can affect the GTP pool in PC12 cells, we exposed PC12
cells to similar oxidizing conditions. Figures 28A and 28B are representative
chromatograms of cytosolic extracts from PC12 cells under control and Cu/Asc-exposed,
oxidizing conditions.
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FIGURE 28
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Figure 28. Chromatographic profiles of GTP in oxidized PC12 cells
Alkaline phosphatase -treated cellular extracts obtained from PC12 cells under control or
Cu/Asc –exposed (1mM L-ascorbic acid, 10 µM copper sulfate) conditions. Typical
elution profiles for oxo8G (A) and G (B) detected at 250mV and 785mV respectively.
Bar graphs demonstrate increases in cellular levels of oxo8G, reported as oxo8GTP (C), in
Cu/Asc –exposed cell populations (black bars) as compare to control (white bars) and
constant levels of G, reported as GTP (D), in both groups. Data expressed as the mean
molar quantities of analyte per total protein (mg) ± SEM (n =6, * p < 0.05).
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We found that a four-hour incubation with Cu/Asc significantly increased cellular
oxo8GTP two-fold from basal levels in PC12 cells (Figure 28B). Detected levels of G and
oxo8G were expressed as GTP and oxo8GTP respectively and normalized to total protein.
Levels of GTP were unchanged between control and Cu/Asc-exposed cell populations
(Figure 28D). GTP levels in untreated PC12 cells (1.5 nmoles GTP/ 106 cells) were
similar to basal levels we previously reported in untreated HEK 293T cells (2.3 nmoles
GTP/ 106 cells) using this method (Bolin and Cardozo-Pelaez 2007).
To determine if the increase in oxo8GTP in PC12 cells with Cu/Asc would have
an effect on sGC activity, we exposed a population of PC12 cells to Cu/Asc for four
hours. After exposure to Cu/Asc, PC12 cells were stimulated with DEA/NO and cGMP
formation by intracellular sGC was measured by HPLC-EC. Both 1 µM and 0.5 µM
DEA/NO–stimulated PC12 cell populations had a two-fold reduction in cGMP formation
after Cu/Asc exposure (Figure 29).
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FIGURE 29
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Figure 29. Inhibition of sGC activity in NO-stimulated, oxidized PC12 cells
Inhibition of sGC activity in DEA/NO-stimulated PC12 cells under control or Cu/Asc –
exposed (1 mM L-ascorbic acid, 10 µM copper sulfate) conditions. Data expressed as the
mean molar quantities of analyte per total protein (mg) ± SEM (n =2-9, * p < 0.05).
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In order to reproduce the protective effects of GSH in cell-free preparations, we
incubated PC12 cells with 1mM or 5 mM of a cell permeable GSH, glutathione ethyl
ester, twenty minutes prior to the addition of Cu/Asc. Neither concentration of GSH was
able to protect GTP from oxidative modification and only at 5mM was a protective effect
on sGC activity observed (Figure 30).
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Figure 30. Effects of GSH on oxidation and sGC activity in PC12 cells
Increase in oxo8GTP formation after incubation of PC12 cells with Cu/Asc (black bars)
as compared to control (white bar) conditions including subsets of cells receiving 1 mM
or 5mM glutathione ethyl ester (GSH) (A). Resulting reduction in DEA/NO-stimulated
endogenous sGC activity in the same populations of PC12 cells as (A) incubated with
Cu/Asc (black bars) as compared to control (white bars) with or without pretreatment
with GSH (B). Data expressed as the means ± SEM (n =3, * p < 0.05 compared to
control, # p<0.05 compared to control without GSH).
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It is important to note the confounding finding that GSH alone resulted in a significant
reduction in cGMP produced in PC12 cells stimulated with NO (Figure 30B). Therefore,
further investigation of the reversal of oxo8GTP production and subsequent sGC
inhibition in PC12 cells needs to be evaluated with alternative antioxidants such as
mannitol or oxycoumarin previously shown to reduce oxidative stress in this cell type
(Jones, Underwood et al. 2007).
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Discussion
We have found that under oxidizing conditions the guanine (Gua) base
incorporated into GTP is sensitive to free radical attack causing the formation of
oxo8GTP. Accumulation of this damaged form of GTP can have deleterious effects on
cell function as evidenced by a reduction in purified sGC activity as well as endogenous
sGC in PC12 cells. Conditions of oxidative stress induced by 1 mM L-ascorbic acid and
10 µM copper sulfate are sufficient to induce formation of oxo8GTP without oxidation of
the Gua incorporated into DNA (Bolin and Cardozo-Pelaez 2007).
To accurately report sGC activity, we developed a novel HPLC-EC methodology
for quantifying cGMP which can be used as a supporting, functional assay for
investigating changes in cytosolic oxo8GTP levels using the same instrumentation in one
cellular extract. We have previously reported the first biomarker assay of this kind for
the measurement of oxidized guanosine triphosphates (oxo8GTP and oxo8dGTP)
simultaneously with their unmodified triphosphate forms (GTP and dGTP) (Bolin and
Cardozo-Pelaez 2007). In order to extend this methodology into an assay of cell
function, we utilized these same HPLC-EC conditions and probed for cGMP. The most
widely used assay for determining the conversion of GTP to cGMP by NO-stimulated
sGC in vitro and in vivo is by radioimmunoassay with commercially available kits (e.g.,
Amersham International, Arlington Heights, IL). However, reverse phase and ionexchange HPLC methods for the detection of cGMP using fluorometric, diode array, UV,
and EC detection have all been described (Yamamoto, Shimizu et al. 1984; Smith, Wales
et al. 1993; Goossens, Leroux et al. 1994; Yonekura, Iwasaki et al. 1994; Pietta, Mauri et
al. 1997; Seya, Furukawa et al. 1999; Diaz Enrich, Villamarin et al. 2000; Soda, Ohba et
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al. 2001). Our detection limit of 13.6 femtomoles is competitive with the most sensitive
of these HPLC methods, that have a detection range between 5 femtomoles and 10
picomoles. The reliability of the method is demonstrated by an average percent recovery
for cGMP standards of 99.8% and a coefficient of variation of less than 5% between
replicate injections. Additionally, under our experimental conditions, sGC activity
produces a strong increase of detectable cGMP stimulated by DEA/NO both in cell-free
preparations of purified sGC and in PC12 cells similar to previously published studies
(Figure 22) (Lee, Martin et al. 2000; Watjen, Benters et al. 2001; Bellamy, Griffiths et al.
2002). Our detected values of cGMP are close to cGMP values previously reported in
this cell type although higher due to our use of a phosphodiesterase inhibitor, more potent
NO donor, and our more sensitive detection methodology (Watjen, Benters et al. 2001).
The advantage of our method lies within our ability to analyze the unmodified and
oxidized substrates (GTP and oxo8GTP) of NO-stimulated sGC along with the enzymatic
product (cGMP) within the same sample.
Employing our sGC assay in vitro we were able to characterize oxo8GTP as a
potent, endogenous inhibitor of NO-stimulated sGC. The most characterized and widely
used inhibitors of sGC to date are methylene blue, LY-83583, ODQ and NS 2028. These
exogenous inhibitors act by either directly or indirectly interfering with NO binding to
the ferrous heme iron which prevents the change in conformation of sGC and subsequent
enzyme activation (Luo, Das et al. 1995; Schrammel, Behrends et al. 1996; Olesen,
Drejer et al. 1998). This type of synthetic inhibition is partially overcome upon
competitive addition of NO donors such as DEA/NO (Schrammel, Behrends et al. 1996).
Due to the fact that high concentrations of DEA/NO were not able to overcome the
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inhibition of sGC by oxo8GTP, we suggest oxo8GTP is not acting at the NO-binding site
(Figure 24). Analysis of double reciprocal plots of substrate (GTP) versus the velocity of
sGC demonstrated a decrease in Vmax with increasing oxo8GTP concentration with little
effect on Km (Table 1). This suggests a noncompetitive, mixed type of inhibition of
oxo8GTP with GTP. However, further analysis of inhibition is necessary to accurately
characterize the specifics of oxo8GTP inhibition on sGC activity.
Interestingly, L-ascorbic acid and cupper sulfate, independently, have been found
to inhibit sGC in a similar cell-free system as the one used in our studies (Schrammel,
Koesling et al. 1996; Schrammel, Koesling et al. 2000). Schrammel et. al. presented data
showing that both copper ions and L-ascorbic acid act as inhibitors of sGC via NOindependent mechanisms and the inhibition is prevented by the addition of GSH.
However, they failed to establish a role for the GTP pool. We report that exposure of
pure GTP to L-ascorbic acid alone leads to an approximately 600 fold increase in
oxo8GTP although incubations of GTP with copper alone do not affect oxo8GTP levels
(Figure 26). Our results suggest that the previously reported observations of sGC
inhibition by L-ascorbic acid and copper sulfate could be due in part to oxidative
modification of GTP present in the reactions, producing the inhibitor oxo8GTP, as
opposed to direct effects on NO binding or direct modification of the sGC protein. This
is further supported by the successful reduction of oxo8GTP levels produced by the
combination of L-ascorbic acid and copper sulfate in our reactions by GSH and
consequent rescue of sGC activity (Figure 26).
Corroboration of our cell-free sGC activity results with findings using the PC12
neuronal cell culture model demonstrates the physiological relevancy of our findings.
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The levels of oxo8GTP induced with Cu/Asc correspond to approximately 24 nM
oxo8GTP in the cell extracts and approximately 50 µM GTP which resulted in a 50%
reduction in cGMP produced by NO-stimulated, native sGC (Figures 24 and 25). This is
very similar to the magnitude of reduction in cGMP in cell-free, NO-stimulated sGC
inhibition observed (Figure 23A, inset). Therefore, although oxo8GTP may only
represent between 0.048 and 0.2 % of the total cellular GTP present, it is able to reduce
the amount of cGMP available via sGC activation by as much as half. This is an
interesting result that might suggest that sGC has a higher affinity for oxo8GTP than the
endogenous GTP substrate. Consequences of lowered cGMP levels in the CNS include
reduced neuronal activation, impairment of long term potentiation (LTP), and the
disruption of neuritogenesis (Zhuo, Hu et al. 1994; Arancio, Kandel et al. 1995; Boulton,
Southam et al. 1995; Tanaka, Markerink-van Ittersum et al. 1997; Bidmon, Starbatty et
al. 2004; Boess, Hendrix et al. 2004; Monfort, Munoz et al. 2004; Yamazaki, Chiba et al.
2006). Further investigation of oxo8GTP levels and resulting changes in sGC could
provide key mechanistic insights into the pathology of normal developmental, aging, and
disease processes known to be highly affected by oxidative stress. This is emphasized by
the fact that the MTH1 protein, responsible for hydrolyzing oxo8dGTP to oxo8dGMP and
thus preventing its incorporation into DNA, has a rate of cleavage 50 times lower for
oxo8GTP than that of oxo8dGTP (Mo, Maki et al. 1992; Hayakawa, Hofer et al. 1999).
No specific repair mechanism for sanitation of cellular oxo8GTP has been identified to
compensate for this inefficiency of MTH1.
Concentrations of L-ascorbic acid and copper sulfate used in this study are
biologically relevant to those found in brain where copper reaches levels as high as 30
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µM during normal neurotransmission (Haeffner, Smith et al. 2005). Additionally,
evaluation of AD brains known to contain concentrations of copper as high as 400 µM in
a cellular environment rich in reducing agents such as ascorbic acid could provide a novel
approach to understand early biomarkers of oxidative stress that appear to precede gross
neuronal death (Lovell, Robertson et al. 1998; Pratico, Clark et al. 2000; Pratico, Uryu et
al. 2001). Further studies evaluating the consequences of oxidative stress induced
elevated oxo8GTP levels and resulting modulations in sGC activity in brain tissue is
necessary to investigate physiological impacts of this novel biomarker. Additionally, it
is necessary to confirm the presence of an oxidized cGMP product, as a result of
oxo8GTP being converted to oxo8cGMP by sGC, and determine how this oxidized cGMP
may behave in downstream processes requiring cGMP.
In conclusion, our results show oxo8GTP to be a potent inhibitor of sGC, and that
oxidative environments induced with Cu/Asc cause an elevation in oxo8GTP that
significantly lowers available cGMP. The methodology outlined within this study to
quantify oxo8GTP and sGC activity concomitantly can be applied to a variety of systems
investigating oxidative stress as a component of pathologies including cardiovascular
disease and neurodegenerative disease. Furthermore, investigating this previously
overlooked biomarker and its cellular consequences may lead to novel therapeutic
interventions for these diseases.
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Conclusions
In this study we report oxo8GTP as an endogenous product of GTP oxidation
under conditions of oxidized stress induced by copper sulfate and L-ascorbic acid that is
reversible with the antioxidant GSH. sGC, a previously uncharacterized target of
oxo8GTP, is also evaluated and shown to be inhibited by oxo8GTP produced in cell-free
preparations as well as oxo8GTP induced in PC12 cells exposed to copper sulfate and Lascorbic acid. Analysis of brains from patients with neurodegenerative disease
pathologies such as AD, known to have elevated levels of endogenous copper in cellular
environments rich in ascorbate and GTP, could yield a more relevant source of
biomarkers for disease state than previously characterized oxidative lesions to G
incorporated into DNA. Analysis of oxidative products such as oxo8GTP could help
facilitate the transition from G being regarded as an endpoint of cellular dysfunction that
leads to carcinogenesis or apoptosis in a cellular state too compromised for effective
intervention to a player in early mechanistic modulations in neurodegenerative disease
such as neuronal signaling.
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SUMMARY
The goal of this study was to test the hypothesis that oxo8GTP is produced under
physiological conditions, increased during oxidative stress, and a consequence of
elevated oxo8GTP levels is a reduction in available cGMP due to its activity as a
pathological inhibitor of sGC. We set out to test this hypothesis by testing the following
specific aims: (1) Determine the levels of oxo8GTP produced in cell-free GTP
preparations and cytosolic extracts from cells in culture under conditions of oxidative
stress induced by L-ascorbic acid and copper using a novel HPLC-EC methodology, (2)
determine the specific mechanism of oxidation to GTP induced by L-ascorbic acid and
copper using EPR, and (3) evaluate the consequences of increased levels of oxo8GTP on
sGC activity in cell-free and cell culture conditions.
Results from experiments testing these specific aims yielded the following
conclusions. In regards to aim 1, HPLC-EC, with preparative dephosphorylation, is a
sensitive, reliable method for measuring GTP, dGTP, oxo8GTP, and oxo8dGTP.
Oxo8GTP is produced in cell-free preparation of GTP under oxidizing conditions (1mM
L-ascorbic acid/10 µM CuSO4) and significant elevations in oxo8GTP are also observed
under the same oxidizing conditions in HEK 293T and PC12 cells. Additionally,
Oxidation of the GTP pool may occur independently of oxidation to 2dG in DNA.
Major results and conclusions from aim 2 are that the OH radical is generated in
reactions of 1 mM GTP/10 µM CuSO4/1 mM L-ascorbic acid as assessed by EPR
spectroscopy. Production of the OH radical is dependent on the presence of GTP and O2
and Cu(II) forms a necessary complex with GTP which facilitates its reduction to Cu(I).
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Differences observed in the percent increase of oxo8GTP in cell-free GTP as compared to
cell culture models can be explained by available O2 in the system.
From specific aim 3 we were able to determined that HPLC-EC is a sensitive,
reliable method for quantifying sGC activity based on detection of the cGMP product.
Oxo8GTP is a potent inhibitor of sGC in cell-free preparations and increases in oxo8GTP
in cell-free preparations by oxidizing conditions (1mM L-ascorbic acid and 10µM
CuSO4) cause significant inhibition of sGC activity which can be recovered by pretreatment with the antioxidant GSH. The observed increases in oxo8GTP in PC12 cells
by oxidizing conditions also causes significant inhibition of sGC activity.
Taken together, the results presented in the entirety of this study provide a new
means of understanding oxidative stress in the normal and disease or toxin-exposed
cellular environment. Application of these methods can provide the tools necessary to
target oxo8GTP as a key biomarker and cellular signal in pathological disease states such
as AD.
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APPENDIX A:
Age-dependent accumulation of 8-hydroxy 2’-deoxyguanosine triphosphate
(oxo8GTP) in mouse caudate putamen
Summary of Method and Results
Male mice both young (aged 2-4 months) and old (aged 22-28 months) SVJ/129
mice were euthanized by cervical dislocation and microdissections of the caudate
putamen performed. Caudate putamen tissues were weighed and immediately placed in
ice-cold, 0.05M perchloric acid. After sonication, samples were centrifuged at 14,000 x
g, 4oC for 20 minutes, supernatants were filtered through 0.45µm syringe filters and
samples stored at -80oC until analysis. On the day of analysis, extracts were neutralized
with KHCO3/KCO3 buffer and subjected to the dephosphorylation procedure using
alkaline phosphatasee exactly as cell extracts in Chapter 1. HPLC-EC analysis of dG, G,
oxo8dG, and oxo8G was also carried out exactly as described in Chapter 1 in 27 µL of
dephosphorylated extract. dGTP, GTP, oxo8dGTP, and oxo8GTP were quantified as
picomoles (pmoles) and expressed per amount of tissue weight in milligrams (mg).
As shown in Figure 1A and 1B, all analytes were detectable in caudate putamen
tissue extracts from a representative young mouse caudate putamen.
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FIGURE 1
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Figure 1. Chromatographic profiles of caudate putamen extract.
Chromatograhic profiles of alkaline phosphatase treated caudate putament extracts in
from young mice. Typical elution profiles for the generated G and 2-dG (A) and typical
elution profile for the oxo8G and oxo8dG generated (B).
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Figure 2 shows that GTP decreases significantly with age, rendering oxo8GTP below
detection limits in old animals. Conversely, dGTP appears to increase with age, and
oxo8dGTP is significantly elevated in old animals as compared to young animals (Figure
2).
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FIGURE 2
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Figure 2. Quantitiation of GTP, dGTP, oxo8GTP, and oxo8dGTP in young and old
mice.
Levels of GTP (A) and oxo8GTP (B) as well as dGTP (C) and oxo8dGTP (D) from
extracts of caudate putament from young (2-4 months) and old (22-28 months) mice.
Data are expressed as mean ± SEM (n = 3-9), * p<0.05).
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These findings are very interesting in terms of known oxidative accumulation to
the guanosine moiety in DNA with age (Fraga, Shigenaga et al. 1990; Cardozo-Pelaez,
Song et al. 1999; Izzotti, Cartiglia et al. 1999; Cardozo-Pelaez, Stedeford et al. 2002). It
can be concluded from our data that the DNA precursor, dGTP, is also subject to an agedependent increase in oxidation. This has never been directly quantified in brain tissue
before. The results of these experiments verify that brain tissue is a viable source of
these biomarkers of oxidation (oxo8GTP and oxo8dGTP) and further studies evaluating
the effects of neurodegenerative disease such as AD or toxicological insult leading to
neurological deficits are possible. The normal fluctuation in oxo8GTP and oxo8dGTP as
well as their unmodified forms with observed with age differences in mouse brain
caudate provide evidence of the vulnerability of this nucleotide pool that merits further
investigation in murine and human brain tissue.
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